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The concept of Type A behavior 
(personality) was introduced in late 
1950s. It evolved from a relatively 
unknown factor to a widely popular 
concept of health research especially 
in 1970s and 1980s, conceived as 
equal to conventional cardiovascular 
risk factors. Since then, research 
findings on the relationship of Type 
A with cardiovascular outcomes 
have been inconsistent, and general 
interest towards this phenomenon has 
decreased remarkably. The findings 
of this study suggest that widely used 
Type A measures do not significantly 
associate with increased mortality.
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ABSTRACT 
 
Background. In the 1950s cardiologists Friedman and Rosenman began to study a 
personality type that they believed was linked to CHD. It became known when they 
published an article about the Type A personality (Type A behavior pattern or TABP). This 
personality was defined as an action-emotion complex characterized by excessive 
competitive drive, intense striving for achievement, easily provoked hostility, 
aggressiveness, impatience, and an exaggerated sense of time urgency. Quantitatively, the 
construct is evaluated using the Structured Interview or self-reported questionnaires such 
as Jenkins Activity Survey, Framingham Type A Scale, Finnish Type A Scale, Bortner 
Rating Scale. Over 50 years of studies have failed to decisively confirm the role of TABP 
characteristics in the development of CVD, negative health outcomes or early death. The 
rationale for this study were historically diffuse findings, and analysis was performed to 
disambiguate the issue by using various assessment tools in one cohort across different 
follow-up time. Additionally, cynicism was analyzed as one of potential ‘toxic’ elements of 
TABP. 
Aims and objectives of study. The main aim was to examine with multiple TABP 
measures, reasonably large population-based sample, broad set of covariates, and long 
prospective follow-up design, whether TABP associates with premature cardiovascular and 
non-cardiovascular mortality in middle-aged-to-aging Finnish men. Study objectives: 1) to 
examine the association between the Type A and cardiovascular mortality; 2) to examine 
the association between the Type A and cardiovascular mortality depending on subjects 
cardiovascular history at baseline; 3) to examine the association between the Type A and 
non-cardiovascular mortality; 4) to examine the association between the cynicism and 
mortality; and 5) to examine the effect of measurement scales and follow-up time on 
associations between the Type A and mortality. 
Study design. The data used in the study has been collected within the Kuopio Ischemic 
Heart Disease Risk Factor Study. It includes a randomly selected representative sample of 
2,682 men residing in Kuopio or its surrounding communities in Finland. At baseline they 
were aged 42–60 years and were followed up from 1984 until 2009 (last data available). 
Results. CVD mortality was inconsistently and mainly non-significantly associated with 
TABP. Majority of the associations showed rather inverse than positive relationships with 
mortality. Non-CVD mortality showed weaker associations with TABP than CVD 
mortality. The cynicism showed predictive validity both for CVD and non-CVD mortality. 
The effect estimates of TABP and cynicism on health were more expressed after 6 and 11 
years of follow-up than after 16, 21 or 26 years. 
Conclusions: 1) In our study, the Type A as measured by different scales tended to be 
inversely associated or not associated with cardiovascular mortality among middle-aged 
and aging men. 2) The inverse associations between the Type A and cardiovascular 
mortality were more expressed among men with cardiovascular history at baseline than 
without. 3) Non-cardiovascular mortality was associated with the Type A mainly in earlier 
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follow-up until about 11 years while the later follow-up showed slight or no risk effect. 4) 
The cynicism seemed to be associated with an increased risk of cardiovascular and non-
cardiovascular death in middle-aged and aging men. 5) The associations between the Type 
A and mortality strongly depended on the Type A scales that showed only moderate 
intercorrelations. Stronger associations were observed with the Framingham and Finnish 
than the Jenkins and Bortner scales, while the follow-up time was related with the strongest 
associations at about 6–11 years of follow-up. 6) There is limited justification for future 
scientific research on associations of the Type A and health outcomes: these associations are 
too much dependent on measurement scales, follow-up time, research decades, cohort 
characteristics, statistical assumptions, and environment while the statistically significant 
findings about associations can be random or specific to other components of personality or 
other behaviors. 
 
 
National Library of Medical Classification: WA 900, WA 950, WG 120. 
Medical Subject Headings: Type A Personality; Cardiovascular Diseases; Mortality; Cohort Studies; Male; 
Epidemiology. 
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1 
1 Introduction 
In the 1950s cardiologists Friedman and Rosenman began to study a personality type that 
they believed was linked to coronary heart disease (CHD). They remarked that there were 
CHD cases that couldn’t be explained by dietary factors, but possibly by socioeconomic 
ones such as occupational pressure or stress at work. It became known when they 
published an article about the Type A personality [Friedman & Rosenman 1959]. This 
personality was defined as having such features as: 
1) intense, sustained drive to achieve self-selected but poorly defined goals; 
2) profound inclination and eagerness to compete; 
3) persistent drive for recognition and advancement; 
4) continuous involvement in multiple and diverse functions constantly subject to 
time restrictions (deadlines); 
5) habitual propensity to accelerate the rate of execution of many physical and 
mental functions; and 
6) extraordinary mental and physical alertness. 
Type A personality can be referred to as an action-emotion complex characterized by 
impatience, sense of time urgency, competitiveness, striving for achievement, 
aggressiveness, hyper-alertness, restlessness, explosive speech, and abruptness of gesture 
[Rosenman 1977]. Additional traits of such personality are quick actions, punctuality, 
hostility, emphatic gestures, and concentration on self-selected goals at the expense of other 
aspects of life. As an opposite type of personality there was defined the Type B who is more 
relaxed and non-competitive, unhurried, more open to broader specter of life experience 
and leisure. It could also be described as a relative absence of Type A features. 
Regardless of many studies conducted this far, there is still no comprehensive 
psychological theory of coronary-prone (or disease-prone) personality and behavior, 
possibly because the history of Type A research has been characterized by non-theoretical 
and over-empirical approach [Julkunen 1988]. Intercultural comparisons are restricted due 
to lack of comparable data across countries, decades, and populations. Of note, many 
authors and epidemiological researchers drop the original definition of the Type A 
personality (or Type A behavior pattern, TABP) by paying not appropriate attention to 
explicitly underlined importance of specific environmental factors in emerging the TABP in 
susceptible persons. One of the authors of the concept emphasized that Type A behavior 
“particularly emerges when relevant milieu conditions elicit Type A behavior in susceptible 
persons” [Rosenman 1990]. This is a complex of observable behaviors displayed by 
individuals in certain provoking circumstances [Carroll 1995]. From this perspective it 
seems that based on Allport’s trait theory, the Type A behavior is rather secondary 
(characteristics seen only under certain circumstances) than cardinal or central trait, which 
makes its investigations widely complex and culture-specific. However, in scientific and 
general community Type A is still commonly perceived as a cardinal trait (characteristics 
that dominates and shapes a person’s behavior). 
This idea (relevance of environment for manifestation of trait or behavior) has often been 
overlooked in epidemiological studies of behavioral risk factors of CHD. Due to this 
complexity of behavior interpretations I refer to the Type A here as ‘Type A behavior 
pattern’ rather than ‘Type A personality’ (like in PubMed), because it is not that somebody 
is the Type A person, but rather that he or she displays the behavior pattern depending on 
life circumstances and environment. The pattern is neither a personality trait nor a standard 
reaction to a challenging situation; instead it is the reaction of a psychologically 
predisposed person to a situation which challenges him or her [Jenkins & Zyzanski 1980]. 
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Friedman & Rosenman [1974] stated that “the most important reason, at least in the 
United States, is the transformation of nineteenth-century Yankee pragmatism into an 
unbridled drive to acquire more and more of the world’s material benefits” (p. 166). They 
continue (p. 167), that “When greed of this sort becomes indiscriminate, and cannot be 
sated by quality but only by numeration, the person involved has become a Type A”. Here 
it can happen that the evolution of Western society has significant impact on manifestation 
and acceptance of TABP within society which later leads to better or worse health outcomes 
(depending on person’s perception of social desirability). Acceptance and demand for Type 
A traits could have led not only to higher prevalence of Type A, but also to broader 
variability within Type A ‘pool’, increasing potential for protective health effects. 
The research on TABP has been widely conducted relating with health outcomes. 
However, the findings are ambiguous – if early decades of research showed clearly 
negative effects of TABP on health (especially considering cardiovascular outcomes), later 
studies revealed that behavior pattern could have no effect on subject’s health. This shift of 
exposure-outcome association can possibly go in parallel with the evolution of Western 
society, keeping in mind the social nature of TABP. Moreover, it is still an open question, 
what is more important from perspective of health – the TABP as an entity or certain 
components of it. Among the latter ones, the hostility has been cited most. 
One of the core issues in TABP research has been the quantitative assessment of the 
construct. The construct is evaluated using the Structured Interview or self-reported 
questionnaires such as Jenkins Activity Survey, Framingham Type A Scale, Finnish Type A 
Scale, Bortner Rating Scale etc. The diffuse findings on associations between TABP and 
health can partly be related with inconsistency of measurements, since the studies used 
different assessment tools (usually one scale across one study) which resulted in complexity 
of comparison of findings. 
Our study is a population-based longitudinal study with 26-years follow-up on middle-
aged and aging Finnish men. The study having four scales for assessment of TABP is 
unique in that it not only enables to evaluate the intercorrelations between the scales but to 
compare their predictive validity for mortality (least biased health outcome) as well. 
Additionally, the study uses unique approach giving an insight into exposure-outcome 
associations depending on follow-up time. This is the first study to apply so many TABP 
measures on the same individuals and such approach to analyses enables to estimate the 
robustness of associations and dependence of them on the method of assessment and on 
follow-up time including control for conventional covariates. Altogether, this study 
provides clearer picture on the issue of Type A and health outcomes. 
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2 Literature review 
An extensive number of studies have been published on possible effects of the Type A 
behavior pattern (TABP) on health. Most of them have analyzed the association between 
TABP and cardiovascular diseases (CVD), especially coronary heart disease (CHD). 
Although the first studies of this kind emerged about 40 years ago, there is no consistency 
in results and clear evidence about effects on CVD risk. It is supposed that the results vary 
due to ambiguity of TABP concept as such and that the Type A is expressed to different 
extent among various social groups. The associations of TABP with other diseases have 
been investigated much less than with CVD. 
To compare, by August 19, 2012 the number of PubMed articles concerning CVD (MeSH 
term “Cardiovascular Diseases”) and the TABP (MeSH term “Type A Personality”) was 
877, while concerning cancer (MeSH term “Neoplasms”) and the TABP – only 27 (32 times 
difference). The reason for this presumably lies in history – in the fact that the start for this 
research and introduction of the concept itself came from cardiologists (Rosenman and 
Friedman), who proposed the idea that certain type of personality can be more prone to 
cardiovascular events. There were also some physiological models developed to explain 
how the incidence of CVD might be related with a particular psychological or social status. 
2.1 TABP AS A RISK FACTOR FOR CVD 
Based on their clinical observations, Friedman & Rosenman [1959] originally stated that 
TABP evokes an increased risk for CHD incidence through behavioral features. They 
observed that there are CHD cases that can’t be explained by dietary factors such as fat or 
cholesterol, but instead by socioeconomic factors such as occupational pressure or stress at 
work [Rosch 2004]. With this hypothesis they launched a prospective study which lead to 
the first evidence about the predictive nature of TABP. The study was a prospective 
epidemiological study called the Western Collaborative Group Study (WCGS), launched in 
1960–1961 and followed up for 22 years. This was the study where Friedman and 
Rosenman devised the Structured Interview (SI) as a tool for measurement of TABP. The 
baseline cohort was 3,154 men aged 39–59 years. The study was double-blind, in that those 
investigators doing the Type A assessment had no knowledge of subject’s health status and 
those investigators assessing CHD risk had no knowledge on the Type A status. The results 
showed that Type A men had more than twice a risk of CHD incidents during the first 8.5 
years of follow-up compared to the Type B [Rosenman et al. 1975]. When the results of the 
whole follow-up were evaluated, the researchers found that among 61–71 years old men 
the behavior type assessed at baseline was positively associated with the morbidity index 
and showed a dose-response relationship. For the older men the pattern was similar but 
already out of statistical significance [Shoham-Yakubovich et al. 1988]. 
Another one prospective study, the Framingham Heart Study (FHS), assessed the TABP 
with a special self-reported scale – the Framingham Type A Scale (FTAS), which predicted 
the CHD incidence during the 8-years follow-up both in men (580 subjects; RR=2.4; 95% CI 
1.1–5.7) and in women (750 subjects; RR=2.0; 95% CI 1.2–3.3). The TABP was most strongly 
related to coronary diagnoses in which angina pectoris symptoms were present [Haynes & 
Feinleib 1982]. However, later it was found that no clear association was observed among 
men relating the TABP and the 10-year incidence of stroke [Eaker et al. 1983]. 
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Similar results were later reported from a number of other studies, including the studies 
from Europe. The Belgian-French Pooling Project [1984] included 2,699 middle-aged men 
and assessed the TABP using the Bortner Rating Scale (BRS), dividing the scores into 
quartiles. The results showed that the relative risk for CHD for the 4th quartile comparing 
with the first one (reference) was 1.70. The researchers found, that the established TABP 
relationship to CHD was independent of age, smoking, systolic blood pressure, serum 
cholesterol, body build, and socioprofessional status. 
After that, the status of TABP concept seemed to shift to the next phase of development 
and investigation. In the first stage, after introduction of the construct, the general opinion 
was rather skeptical and harsh criticism was directed to the nature and validity of TABP 
[Friedman & Rosenman 1974]. After positive relationships from studies started to emerge, 
the general approach changed quite rapidly and evoked an enthusiasm to launch different 
studies related to this construct. The climax of this trend occurred in early 1980s, when in 
the USA there was concluded that the TABP (as assessed by Structured Interview, Jenkins 
or Framingham scales) was associated with an increased CHD risk, at least among 
employed, middle-aged American citizens. As a result of expert panel meeting in 1978, the 
Type A was added to the official list of risk factors for CHD by the National Heart, Lung 
and Blood Institute of the National Institutes of Health [Cooper et al. 1981]. The relative risk 
was estimated to be equal to the risk of conventional risk factors, such as high total 
cholesterol level, hypertension or cigarette smoking. The experts claimed, that the “type A 
behavior … is associated with an increased risk of clinically apparent CHD in employed, 
middle-aged US citizens” [Cooper et al. 1981, p. 1200]. However, the panel stated that they 
had serious reservations concerning the understanding and assessment of TABP. They 
called for improved measurements that would be valid and consistent as well as more 
attention for physiologic mechanisms (such as stress reactions), cultural and gender 
differences and even intervention trials. Similar generalizations were stated by Jenkins & 
Zyzanski [1980] who made a systematic review of studies and claimed the argument for 
validity of concept as a “genuine international risk factor for CHD”. Based on the studies 
reviewed they suggested that TABP or cultural variations of it are associated with CHD 
despite differences in genetic characteristics, social factors, geography, and political or 
economic system. 
One of the possible reasons, why the results were mostly showing positive relationships 
between TABP and cardiovascular outcomes in the first decades could be the publication 
bias [Miller et al. 1991] [Chida & Steptoe 2009]. Meanwhile Haynes & Matthews [1988] 
proposed another explanation for the trends towards absence of associations. They 
concluded that TABP was a risk factor for CHD in population-based studies, but the studies 
of high risk populations “fail to consistently support the hypothesis that Type A behavior is 
a risk factor for recurrent events or for mortality”. They suggested that a drift in the 
definition of TABP, changes in health behaviors and treatment patterns due to widespread 
increased awareness of TABP, decreases in cigarette smoking rates and decreases in CHD 
mortality in general could all have caused the weakened relationships of TABP to CHD. 
Still, the TABP stays as the most extensively studied psychosocial risk factor of CHD 
[Julkunen 1996]. It has also been claimed to be the best established behavioral risk factor. 
However, after the wave of positive findings a number of major studies failed to show the 
relationship of TABP and CHD. The controversy emerged about the validity of TABP as a 
risk factor for the development of CVD. It has been published an increasing number of 
negative findings about TABP as a predictor of CHD incidence and outcomes [Matthews & 
Haynes 1986] [Booth-Kewley & Friedman 1987]. 
Perhaps the best-known example of negative findings was the Multiple Risk Factor 
Intervention Trial (MRFIT) which was a carefully conducted clinical trial designed to alter 
cardiovascular risk factors in high risk men [Shekelle et al. 1985]. It was a large scale study 
in 1973–1976, including 12,772 men assessed with the Jenkins Activity Survey (JAS) scale 
and 3,110 of them – with the Structured Interview. The results failed to show any 
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significant prospective association between the JAS scores or the SI ratings and the first 
major coronary events. These and other negative results reopened the debate about validity 
of the Type A construct as a risk factor of CHD. The authors of the MRFIT study pointed 
the necessity to investigate this question and to evaluate the validity of TABP assessments. 
It should be mentioned, that the sample of this study was a high risk population, namely 
the men in the top decile of CHD risk based on their levels of cigarette smoking, serum 
cholesterol, and blood pressure, while the Type A was highly prevalent (over 60%). 
Therefore, such sample could be regarded as high risk sample. 
On the other hand, the Recurrent Coronary Prevention Project [Thoresen et al. 1982] 
reported the results which provided support for viewing the TABP as a causal risk factor 
for CHD in a high risk population. In contrast, another example of a study, failing to find 
the association, was the Honolulu Heart Program, including 2,200 men of Japanese descent 
[Cohen & Reed 1985]. These men were administered the JAS and followed up for 8 years to 
develop CHD. This sample was characterized by low incidence of CHD. Subsequently, no 
relationships between TABP and incidence of total CHD, myocardial infarction, or angina 
were observed. The incidence data showed that the JAS scores were not predicting CHD in 
low risk population with a small number of Type A subjects. Moreover, the British Regional 
Heart Study, including 6,177 men from 19 towns found that TABP as measured by Bortner 
scale was associated with lower CHD incidence, though the association was statistically 
non-significant and was attenuated by the effect of other risk factors [Johnston et al. 1987]. 
Another one study has used the Jenkins scale as an assessment tool for TABP at a large 
scale (1,949 males and females), but found opposite associations [Rime et al. 1989]. Type As 
reported not only more CHD, but peptic ulcers, thyroid problems, asthma, and rheumatoid 
arthritis as well. Of note, these diseases were self-reported and not clinically diagnosed. The 
study showed that more Type A than Type B subjects reported having been ill, and the 
average number of reported diseases per person was higher among Type As than Type Bs. 
It was observed in spite of the fact that the Type As were markedly younger than Type Bs, 
and despite the empirically based reputation of the former to be symptom deniers rather 
than symptom reporters. Possibly, the age structure of the sample could have influenced 
the findings, because Williams et al. [1988] showed, that the relationship between TABP 
and CVD can be dependent on age – the younger age, the stronger association. Overall, the 
findings reported by Rime’s et al. [1989] supported the idea that TABP is not only a specific 
coronary-prone, but a general disease-prone condition. 
Using the WCGS data, Ragland & Brand [1988a] showed that the Type A patients with 
CHD at baseline had lower subsequent mortality. There, the relative CHD-associated 
mortality rate among Type A compared to Type B patients was 0.58 (P=0.03) in both 
younger and older subgroups. It was observed in that same WCGS cohort which boosted 
the idea of TABP as independent risk factor for CHD. This advantage associated with TABP 
is surprising and needs confirmation, because the sample size was relatively small (257 
men). 
It should be noticed, that the other phenomena related to TABP were also detected. 
Williams et al. [1988] studied the relationship between TABP and coronary atherosclerosis 
(CAD) within a sample of 2,289 patients undergoing diagnostic coronary angiography in 
1974–1980. Using the Structured Interview they found, that TABP was significantly 
associated with CAD severity after age, sex, hyperlipidemia, smoking, hypertension, and 
their various significant interactions were controlled for. However, this relationship was 
depending on age – Type As aged 45 or younger showed more severe CAD than Type Bs, 
while among patients aged 55 years and older the association was inverse. These 
researchers also used the Jenkins scale – a self-reported questionnaire and it was not related 
to CAD severity at all. The authors emphasized the need for future research focusing more 
specifically on such TABP components like hostility and anger, and particularly in younger 
samples. 
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The influence of age was observed in another one study [Siegman et al. 1987a], where the 
positive association between expressive hostility and severity of CAD was observed only in 
patients aged 60 and less. Apparently, older patients may represent a group of particularly 
hardy survivors in which psychosocial influences on disease are resisted by certain 
constitutional make-up. On the other hand, researching TABP in hospital patients and 
coronary occlusion relationship, Siegman et al. [1987b] found no significant correlations 
between patient’s global Type A scores assessed by the Structured Interview and their 
occlusion scores. Separate calculations for older and younger patients did not alter these 
negative findings. Consequently, due to those ambivalent findings, Siegman proposed a 
need to consider age when investigating the relationship between psychosocial risk factors 
and CHD. 
Eaker et al. [1989] found that in the FHS sample, men with higher education level had 
higher Type A scores (the education of more than 12 years compared to that of 8 years or 
less). The Type A was more prevalent among white collar workers than in persons of other 
occupations. It stays consistent with the empirical finding of Finnish students by Kaikkonen 
& Kokkinen [1988; cited in Julkunen 1988], who revealed that students in so called 
enterprising fields (economics, administration, etc.) were highest on the Type A scores. 
Quite unique approach was presented by one of the concept authors Friedman et al. 
[1986]. In randomized trial of patients who suffered acute myocardial infarction they 
reported that TABP can be modified and thus subsequently lead to decreased levels of 
cardiovascular risk. They followed up the study arms for 4.5 years, the first being exposed 
to cardiac counseling, the second – to cardiac counseling as well as to TABP counseling, 
and the third – to no counseling. The second group ended up in 35.1% reduction of TABP 
compared to 9.8% in the first group. Additionally, cardiac recurrence rate was 12.9% in the 
second group, 21.2% in the first, and 28.2% in the third group, showing quite large effect of 
counseling on risk reduction. However, the question remains about the long-term 
maintenance of altered behavior as well as effective components of it. Moreover, talking 
about TABP as exposure the potential for bias exists when re-reporting the personal traits 
after intervention program. 
2.2 PHYSIOLOGICAL MECHANISMS 
The mechanisms by which the Type A exerts a pathogenic influence have been under 
extensive investigation [Matthews & Haynes 1986]. The chief hypothesis being tested is that 
the Type A chronically responds to various environmental events with greater sympathetic 
nervous system and adrenomedullary activity than Type B and that this heightened 
reactivity accounts for coronary risk of the Type A. Friedman suggested that 
norepinephrine is elevated only prior to, during, and after competition and is not elevated 
during the Type A activities of a non-threatening nature. It was suggested by some 
researchers [McMurray et al. 1989] that the Type A individuals are different in the control 
of hypothalamic-pituitary-adrenal axis. 
Zyzanski et al. [1976] studied 94 men, who had been referred by private cardiologists to 
medical center for angiography. The results showed that men with 50% or greater occlusion 
in two or more vessels had significantly higher JAS scores on global scale and subscales 
than those with less expressed disease. Franck et al. [1978] studied 147 patients referred 
because of clinical symptoms of CAD. A large proportion of men (73%) were classified as 
Type As using Structured Interview. Multivariate analyses showed that after controlling for 
cholesterol, sex, age, smoking, and high blood pressure, the TABP was associated with the 
number of vessels occluded 50% or more. However, another report done by Dimsdale et al. 
[1979] on 103 men, examined the association of both the SI and JAS measures and number 
of vessels occluded 50% or more, and they were not able to find straight or inverse 
relationships between TABP score on the one hand and various indicators of atherosclerosis 
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on the other. Young et al. [1984] found no relationship between the Type A score and extent 
of occlusion, though they showed that it was strongly associated with diagnoses of angina, 
but not with that of myocardial infarction (MI), independently of major risk factors for 
CHD. Efforts to detect the association between the BRS score and CAD have been failed 
[Matthews & Haynes 1986]. 
Still, it is not clear how the Type A is linked to CHD. Recent research has more 
investigated this issue and has focused on heightened neuroendocrine activity of the Type 
A person, which is related to the stress and development of CHD. The Type A subjects tend 
to have more sympathetic activity and catecholamine secretion during stress, while the 
Type Bs have more parasympathetic activity. Overtime the heightened sympathetic 
reaction occurring during the stress or being angry or hostile may cause damage to 
cardiovascular system. Excessive epinephrine and norepinephrine cause vasoconstriction, 
what may cause the heart to work harder and produce small lesions in artery walls, which 
in turn results in a build up of atherosclerotic deposits. These catecholamines also affect 
platelet aggregation involved in clotting. Maybe a genetic predisposition towards 
heightened neuroendocrine reactivity to stress could be one of the features that develop the 
Type As in response to it. If so, the Type A behavior may not be causally linked to CHD, 
but it may be an attempt to cope with increased reactivity to stress [Meagher 2002]. 
Such assumptions were partly confirmed in animal research. Manuck et al. [1983] [1989] 
investigated monkeys and their stress reactions. The monkeys who reacted with higher 
heart rate were found to have greater coronary atherosclerosis than others. In another study 
it was found that there exists a correlation between TABP and degree of coronary 
narrowing on angiography [Franck et al. 1978]. 
Altogether, Johnston [1993] remarked that most investigators appear to assume that the 
TABP acts in a way that increases the likelihood of patient developing CAD through 
development of atheroma. Harbin [1989] made a statistical analysis of more than 70 studies 
and concluded that Type A men show greater increases in blood pressure and heart rate 
than Type B during challenging tasks such as video games. However, the effect seems not 
be valid for women and is very dependent on the task used or measurement tool of TABP. 
2.3 REVIEWS AND META-ANALYSES 
There have been performed several overview studies, including meta-analytical studies on 
the issue of TABP and CVD association. They point different reasons for ambiguity of 
findings and the debate is still open. Probably, it shows the actual complexity of TABP as a 
concept. 
One problem in this debate, exemplified by review of Kornitzer [1992], has been the 
failure to clearly distinguish the studies based on healthy, CHD-free population samples, 
and the studies based on either high risk individuals or patient samples. The majority of 
population studies still seem to support the role of TABP as a risk factor for CHD 
[Matthews & Haynes 1986] [Booth-Kewley & Friedman 1987]. The latter concluded that 
TABP was reliably but modestly associated with CHD (responsible for about 2% of CHD 
variance), that the Structured Interview is much better predictor of CHD than self-reported 
questionnaires, that only hard-driving, competitive and hostile elements of TABP were 
related to CHD, and that the effect sizes were smaller in prospective studies than in cross-
sectional studies. The latter point can explain why Rosenman and Friedman had rationale 
to raise the hypothesis from their professional observations, which are rather in nature of 
cross-sectional type (physicians practice has limited follow-up and is relatively biased in 
terms of personality evaluation). Additionally, they recommended that the measurement of 
coronary-prone behavior be narrowed to eliminate, for instance, job involvement and other 
elements of TABP that had been shown to be non-predictive. On the other hand, the 
majority of negative findings came from studies that investigated patient samples or 
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selected high risk samples [Shekelle et al. 1985] [Ragland & Brand 1988b]. Therefore, the 
role of TABP as a secondary risk factor, i.e. predicting recurrent cardiac events, seems to be 
considerably less clear than its role as a primary risk factor. 
Another possible explanation of conflicting results is the issue of assessment techniques 
of TABP. Most of the above-mentioned reviews agree that self-reported methods of the 
Type A tend to produce clearly more negative findings than the studies applying the 
Structured Interview. Consequently, the validity of self-reported measures of TABP as 
indicators of coronary-prone behavior and as predictors of MI or cardiac death has been 
questioned. Due to practical and logistic demands of large-scale population studies, 
however, the use of self-reported techniques is likely to continue [Dembroski & Costa 1988]. 
This is also exemplified in efforts to develop new Type A questionnaires, as well as in re-
analyses of factor structures of the existing scales [Spence et al. 1987]. 
The critical attention of existing measures has underlined the need for greater 
recognition of multidimensionality of the Type A construct and a more adequate coverage 
of all TABP elements. The unsatisfactory predictive validity of most of the self-reported 
measures of TABP has been usually explained by the failure of these methods to adequately 
cover the hostility-related elements of the construct [Matthews & Haynes 1986]. For 
example, the JAS actually includes only a few items related with anger and hostility. One 
possible solution to this problem would be the application of specific measures for 
assessment of hostility together with the Type A questionnaires. Focusing more vigorous 
research on various aspects of hostility can also be necessary. The authors of that meta-
analytical study supposed, that the components of TABP might be more sensitive 
predictors than the global TABP score because the key ‘toxic’ element of TABP may be the 
hostility and anger expression. 
Matthews & Haynes [1986] explained the consistency of negative findings mostly by 
having high risk samples. The other explanation for recent negative results was that those 
studies begun at a time, when the rates of CHD mortality were declining rapidly and 
together with the changes in severity. In parallel, there have been enormous population 
changes in health behavior (smoking, exercise, diet) and treatment (medicines as well), 
which all may influence the risk associated with TABP, even in synergistic manner. 
For the first time the meta-analysis with positive findings for TABP and CHD association 
was challenged by Matthews [1988] who used different decision rules and updates after 
Booth-Kewley & Friedman review [1987]. Her results showed that the Type A is not a 
reliable predictor of CHD incidence, when the number of independent studies and number 
of participants in those studies are weighted. However, she concluded that those 
associations are significant in population-based studies. 
Meanwhile, Schwalbe [1990] compared five well-known prospective cohort studies in 
order to evaluate the relationship between TABP and CHD. He pointed that the WCGS 
study demonstrated increased risk for CHD in Type A males and follow-up revealed a 
greater incidence of second myocardial infarction. The FHS study showed higher rates of 
CHD in Type A men and women, while the MRFIT study and the third evaluation of the 
WCGS study revealed no associations between TABP and CHD morbidity or mortality. 
Schwalbe stated that it is impossible to conclude that the Type A personality is a risk factor 
for CHD. 
Another one review analysis was performed by Miller et al. [1991]. They found, that: 1) a 
type of range restriction bias and disease-based spectrum bias produced many null 
findings; 2) self-reported measures of TABP were often associated with null findings. 
Finally, null results were found for all studies that used fatal myocardial infarction as a 
disease criterion. They emphasized the role of assessment, since the TABP assessed by the 
Structured Interview is associated with CHD. The sample issue was touched as well: there 
were found more Type As in diseased populations of middle-aged men (70%) than in 
healthy ones (46%). 
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The review of all available English and German articles published from 1983 to 1992 on 
association between TABP or hostility on the one hand and CHD or physiological variables 
on the other, was performed by Myrtek [1995]. This was an update of Booth-Kewley & 
Friedman [1987] analysis. He used certain criteria for inclusion based on effect sizes. While 
analyzing the TABP and disease’s relationship and association with physiological reactivity 
he failed to find any stronger relationship. The weak point of this meta-analysis was that 
the establishment of associations was built on Pearson’s correlation (assumption that there 
exists a linear relationship between the exposure and outcome). Following interpretation of 
such findings could state that there is no linear relationship between TABP and CHD, but 
this does not mean that there is no relationship of any other kind (e.g. exponential, U-
shaped or J-shaped). 
An updated meta-analysis that included the studies published from 1966 to 1998 and 
referred in Medline was again performed by Myrtek [2001]. The methods for meta-analysis 
were slightly different, but showed similar findings like the previous overview study. Here 
the effect size for association with CHD was 0.017 when measured by the SI and 0.000 (i.e. 
no effect) when measured using questionnaires. Meanwhile, the hostility was more 
associated with CHD (total effect size 0.022). Very similarly, the most recent review of 
systematic reviews and meta-analyses performed by Schulman & Stromberg [2007] 
concluded that the existing data do not support a meaningful clinical relationship between 
current measurements of these traits and development of CVD. 
From the perspective of epidemiology, if important variation (modification) of effect 
exists, one or more studies that focus on different subgroups may be more effective in 
describing it than the studies based on representative samples [Rothman et al. 2008, p. 169]. 
This supports the necessity of studies and analyses on certain subsamples and not merely 
on representative samples. 
There have been several studies on the issue of TABP conducted in Finland. The Finnish 
Twin Cohort Study [Koskenvuo et al. 1983] used the Bortner scale on 35–64 old Finnish 
men and failed to support the relationship between TABP and incidence of CHD. Julkunen 
in his study on 92 individuals used the Finnish scale for TABP assessment and investigated 
its associations with health outcomes. The study included 76 men and 16 women aged 
below 65 years, who were survivors of acute phase of the first MI [Julkunen et al. 1993]. 
This was a short follow-up that has observed the subjects for a one year looking to the 
endpoints of MI. The study was not able to find associations with TABP measured by the 
Finnish and Jenkins scales in that short-term period. 
The Cardiovascular Risk in Young Finns Study is a prospective population-based follow-
up study of coronary heart disease risk factors in Finnish children, adolescents, and young 
adults. For TABP assessment they used Hunter-Wolf A-B Rating Scale. The findings from 
this study, including 752 subjects [Hintsa et al. 2010] showed that TABP strongly and 
significantly correlated with aggression (r=0.72), eagerness energy (r=0.74), and leadership 
(r=0.67). The analysis of 1014 subjects [Keltikangas-Järvinen et al. 2007] showed that in men 
the eagerness-energy component was associated with significantly thicker carotid intima-
media, while in women the hard-driving component at baseline but not later was 
associated with thinner carotid intima-media. The other components of Type A behavior 
(impatience-aggression and leadership) were not associated with intima-media thickness. 
The same study showed that TABP negatively correlates with somatic risk factors in boys, 
but positively – in girls [Keltikangas-Järvinen & Jokinen 1989]. 
There was also some research conducted based on the Kuopio Ischemic Heart Disease 
(KIHD) study data. There were analysis of cynical distrust [Everson et al. 1997] that showed 
that in average follow-up time of 9 years, the upper quartile had the hazard rate ratio 
between 2.0 and 3.0 both for CVD and non-CVD mortality. The study of 20 extreme Type 
As and 20 extreme Type Bs [Venalainen & Salonen 1992] analyzed object relations, ego 
defenses, and their defects in the psychodinamically oriented interview, but not 
associations with health. 
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In general, talking about the TABP studies in Finland it can be noted that the Type A 
associations with health outcomes are rather meager, while the components are more 
related with health outcomes, especially the cynicism. 
2.4 COMPONENTS OF TABP. HOSTILITY 
Although the Type A was originally defined as a global construct, several authors tried to 
identify the specific pathogenic or coronary-prone aspects in the construct. For example, 
using the WCGS study sample, Matthews et al. [1977] made an effort to identify a subset of 
key ‘toxic’ factors in TABP. They reported a factor analysis of variables using the Structured 
Interview, which resulted in 5 primary factors. Only two of these factors, labeled 
Competitive Drive and Impatience were associated with a subsequent occurrence of CHD. 
Results of another re-analysis of two data sets showed that out of 12 rated Type A 
dimensions only 2 were predictive: overall ratings of potential for Hostility and self-reports 
of holding Anger-In [Matthews & Haynes 1986]. 
Another, parallel kind of approach has focused on analyzing the factor structure of the 
self-reported measures of TABP. Originally, in addition to the global Type A score, the JAS 
has been reported to include three factors: Job Involvement, Hard Driving and 
Competitive, and Speed and Impatience [Jenkins et al. 1979]. The poorly established 
predictive validity of JAS subscales as predictors of CHD end-points has been criticized in 
literature [Krantz et al. 1988], however, Spence et al. [1987] have claimed that the JAS 
essentially consists of two main factors which they have labeled Achievement Strivings, 
and Impatience-Irritability. They have also argued that the first factor could be a positive 
factor for health while the second one would imply a hazard to health. 
The factor analysis of the Finnish Type A Scale (FINT) resulted in identification of two 
factors that were later called Impatience-Irritability and Ambition-Energy [Julkunen et al. 
1993]. 
There is evidence to suggest that the persons demonstrating high levels of TABP are 
more involved to road traffic accidents and more self-reported occupational stress [Evans et 
al. 1987], though it was also found that the TABP as measured by the JAS and BRS is 
associated with faster driving but not with increased risk of accidents [Clarke & Cooper 
2004]. 
The existence of possibly contradictive elements for health in self-reported Type A scales 
is a question which could partly explain a number of contradictory results with these 
measures. If convincing support could be presented for this hypothesis it would also have 
important implications for the re-evaluation and planning of possible rehabilitation 
programs for cardiac patients. 
Investigations on ‘toxic’ components of TABP have been mostly done on hostility while 
the other aspects have received less attention. Though one Finnish study investigated the 
role of leadership in TABP, but it was rather found as a protective component of young 
Type A personality due to positive associations with higher physical activity [Yang et al. 
2012], though they used less conventional Wolf-Hunter A-B Rating Scale. Similarly, serum 
lipids and pulse frequency, but not blood pressure can be associated with Type B rather 
than Type A [Keltikangas-Järvinen & Jokinen 1989]. The study of 20 extreme Type As and 
20 extreme Type Bs within KIHD sample [Venalainen & Salonen 1992] found that Type A 
men were more narcissistic, exploitative, and splitting, had more disordered ego defenses 
compared to Type B. 
On the other hand, gender could be one of effect modifiers, where the TABP can be 
negatively correlating with somatic risk factors in boys, but positively – in girls 
[Keltikangas-Järvinen & Jokinen 1989]. Additional to that, the analysis of 1014 children, 
adolescents, and young adults [Keltikangas-Järvinen et al. 2007] showed that in men the 
eagerness-energy component was associated with significantly thicker carotid intima-
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media, while in women the hard-driving component at baseline but not later was 
independently related to thinner carotid intima-media. The other components of Type A 
behavior (impatience-aggression and leadership) were not associated with intima-media 
thickness. However, the gender could not serve as a component of TABP due to its 
biological nature. 
Hostility is an amalgam of concepts including anger, aggression, disgust, suspicion, and 
cynicism [Whiteman et al. 2000]. It is typically characterized by a suspicious, mistrustful 
attitude or disposition toward interpersonal relationships and wider environment. It is a 
personality trait [Everson-Rose & Lewis 2005] in contrast to the Type A that is rather not a 
trait but a sort of interaction between personality and environment. 
The results from studies are partly ambivalent, though the first meta-analysis of 45 
studies published before 1996 [Miller et al. 1996] concluded that the hostility is an 
independent risk factor for CHD and all-cause mortality. Later studies also showed rather 
positive findings (that hostility associates with higher risk of CVD) [Everson-Rose & Lewis 
2005], among which was also one analysis from the KIHD study [Everson et al. 1997], 
where as an exposure the Cynical Distrust Scale was used and as an outcome the mortality 
with mean duration of 9 years follow-up was chosen. However, another meta-analysis 
[Myrtek 2001] revealed rather null associations and the author concluded that the data 
available is much smaller for hostility than for TABP. Only 15,000 persons in 10 prospective 
studies could be analyzed. The cumulative result of all these studies (‘soft’ or ‘hard’ 
outcomes, healthy persons or CHD patients) yielded the total effect size that was small 
(R=0.022). The association between hostility and CHD was statistically significant but the 
practical meaning for prediction and prevention is questionable. To put this into 
perspective of interpretation, a population effect size of R=0.10 is considered small, R=0.30 
moderate and R=0.50 high. 
Based on the review of studies [Pickering et al. 2003], high level of hostility is associated 
with a more rapid progression of atherosclerosis, more ischemia, a faster rate of restenosis 
after angioplasty, and a higher probability of the recurrent MI. Wu et al. [2001] conducted 
review of psychosocial factors, including TABP and hostility, and concluded that the 
pathophysiological mechanisms of such factors on the pathogenesis of CVD are: 1) 
excessive sympathetic nervous system activation, 2) triggering of myocardial ischemia, 3) 
promotion of arrhythmogenesis, 4) stimulation of platelet function, and 5) deterioration of 
endothelial function. 
The most recent meta-analysis of 44 studies suggests small effect sizes (though 
statistically significant due to large total sample) in both apparently healthy individuals 
(HR=1.19, 95% CI 1.05–1.35) and patients with CHD (HR=1.24; 95% CI 1.08–1.42) [Chida & 
Steptoe 2009]. The harmful effect of hostility was more expressed in men than women. The 
authors of meta-analysis stated that there were indications of publication bias before. Of 
note, only few studies investigated the hostility as measured by the Cook-Medley Hostility 
Inventory (CMHI) questionnaire on CHD-free individuals. 
Hostile individuals are seen as responding to potential stressors with larger and 
prolonged heart rate, blood pressure, and neuroendocrine (cortisol or catecholamines) 
changes than other people. In recent studies, hostility was positively associated with 
inflammatory markers, suggesting another psychophysiological mechanism linking 
hostility with CHD and other negative health outcomes as well as with increased exposure 
to interpersonal stressors and reduced social support [Smith & MacKenzie 2006]. These 
psychosocial conditions could all contribute to negative health outcomes. 
In general it can be noted, that the associations of TABP and hostility with health are 
quite similar and have relatively many supporting and objecting studies. In this study the 
hostility is synonymously used with cynicism, because the measurements used for estimate 
of hostility under study are based on the Cynical Distrust Scale, which is derived from the 
Cook-Medley Hostility Inventory [Miller et al. 1995]. 
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2.5 ASSESSMENT OF TABP 
There are various ways and tools for assessment of the Type A personality. Most common 
are self-reported questionnaires, though originally the assessment of TABP was based on 
an interview, called the Structured Interview, which still remains a sort of ‘golden rule’ 
[Julkunen 1996] for TABP assessment. It is the interview managed by an instructed expert 
and used to be considered as one of the best predictors of CHD. This interview contains the 
questions by which a person is asked about its intrinsic manner of reacting to various 
situations with the purpose to elicit impatience, competitiveness, and hostility [Matthews & 
Haynes 1986]. Some questions are presented deliberately in the way to elicit features of 
behavior indicative of TABP as trustful as possible. As a result, the classification of behavior 
pattern is based not only on subject’s self-reports about TABP, but also on speech stylistics 
and behavioral manners observed during the interview. 
The Structured Interview includes 25 questions about responses of individual to the 
daily stressors that are likely to elicit TABP features such as impatience, hostility or 
competitiveness. The author of this interview claims that “it is generally possible to classify 
from 80% to 90% or more of subjects as predominantly Type A or Type B” [Rosenman 
1978]. Not only the verbal information from answers is considered, but the manner of 
speech, the behavior during interview and other non-verbal information as well. Carroll 
[1995] stated that the speech characteristics (such as interruptions, rapid speech or overt 
hostility) are more important than the answers themselves. The interview is conducted in a 
bit provocative manner in order to elicit TABP features. The result of interview is a 
classification to one of 4 categories – A1, A2 (both Type A, but the former more expressed 
than the latter), B (Type B or the absence of Type A features), and X (intermediate between 
Type A and B). 
Friedman with a team [Thoresen et al. 1982] has developed a modified method – the 
Videotaped structured interview. This interview is delivered in a more empathic and 
unchallenging manner. Unfortunately, the application of the SI demands a properly trained 
interviewer, what makes this assessment expensive and time consuming, especially in 
large-scale population studies. This aspect is commonly acknowledged in justifying the use 
of TABP questionnaires instead of interviews [Edwards et al. 1990]. Another issue is the 
subjectivity of interviewer, in a bigger or smaller extent, and subjective nature of scoring 
procedure for the SI [Siegman et al. 1987b]. Therefore, there have been designed less costly 
self-reported questionnaires. The questionnaires were developed for use in those kinds of 
large-scale studies where it was not feasible to train large numbers of interviewers 
necessary and to invest the time to individual interviews with an entire study population. 
The first well-known scale for self-report was designed by Jenkins team and is the most 
common questionnaire to evaluate the TABP. This was called the Jenkins Activity Survey 
for Health Prediction, or the JAS scale [Jenkins et al. 1965]. Almost by the same time Bortner 
constructed another scale and called it the Bortner Short Rating Scale or BRS [Bortner 1969]. 
There are also some more novel types of testing, such as the Framingham Type A Scale 
[Haynes et al. 1980], the Finnish Type A scale [Järvikoski & Härkäpää 1987] and others. The 
Finnish scale has been developed as a short self-reported questionnaire for the assessment 
of TABP, which was shown to discriminate persons with typical, severe angina pectoris 
symptoms or symptoms indicative of myocardial infarction from symptom free persons. 
Recently, another scale was proposed by Spanish psychologists [Rodríguez Sutil et al. 
1998], who developed so called ERCTA scale for the Type A personality, including 8 items. 
Meanwhile in Japan, Maeda Type A scale [Maeda 1985] is used more widely than other 
Type A scales. 
Even though the Bortner and Jenkins scales were claimed to fail to include the total 
psychomotor behavioral dimension which includes the voice, nevertheless, they were both 
found to agree satisfactorily with the Structured Interview as used in the original 
collaborative group study [French-Belgian Cooperative Group 1982] and in the Belgian 
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Heart Disease Prevention Project [Kittel et al. 1986]. Bortner scale was translated to French 
and validated for the French population against the Structured Interview [Belgian-French 
Pooling Project 1984] and the agreement was 71.5%. 
So far, the SI seems to be the most valid predictor of CHD events. Still, as one of the 
biggest confounders in failing to assess the association between TABP and CHD is the use 
of different assessment tools. And even though the different assessment scales partially 
overlap, they measure different aspects of personality. More to that many questionnaires 
have developed subscales, measuring narrower psychological concepts with even less 
potential for interscale comparisons. The reasons for this emerged during later research, 
which indicated that some aspects of TABP can be more strongly correlated with CHD than 
the other aspects. Moreover, the hostility as one of such factors seems to be related to 
atherosclerosis independently of the Type A. The cynicism (or cynical hostility, sometimes 
synonymously referred to simply as hostility) has also been related with cardiovascular 
outcomes, and usually is assessed using the Cook-Medley Hostility Inventory. Another 
aspect of TABP is anger, usually suppressed anger, supposed to predict atherosclerosis. 
Together, hostility and anger interact so that people high on both have higher levels of 
atherosclerosis. However, there is some controversy over whether both expressed and 
suppressed anger are predictive. 
The Cook-Medley hostility scale [Cook & Medley 1954], derived from the Minnesota 
Multiphasic Personality Inventory (MMPI), was initially designed as a measure of student 
rapport among teachers. Interest in the scale arose among behavioral medicine researchers 
in early 1980s when the associations between CMHI scores and angiographic findings were 
reported [Williams et al. 1980] and when prospective associations were shown with 
cardiovascular events or mortality [Barefoot et al. 1983] [Shekelle et al. 1983]. However, 
over the years the initial excitement about the measure has given way to a more critical 
analysis of its internal consistency and validity of the construct. 
There were only two articles presenting the study with the retest of Type A later on 
during the follow-up. The first study [Carmelli et al. 1991] found that in more than 20 years, 
61% of the WCGS subjects left within the same group like baseline, while 39% changed 
(more from B to A than from A to B, which rather supports the shift of the Western society 
towards A-prone or A-tolerant style). Type Bs compared to As were younger, retired 
earlier, had better health and less managerial or professional positions. Another study 
[Carmelli et al. 1992] found that there exists only a modest test-retest correlation of the SI 
components over a period of over two decades – from 0.29 to 0.55. All this suggests that the 
exposure measurement based on baseline status only has potential for bias in analysis in 
that it omits possible exposure changes in later years. 
2.6 PROBLEMS IN TABP RESEARCH 
Altogether, the research on TABP had taken 5 main forms [Johnston 1993]: 
• prospective studies of TABP; 
• studies of TABP and coronary artery disease; 
• attempts to isolate the important components of TABP; 
• studies of the modification of TABP; 
• examination of the possible physiological mechanisms relating TABP to coronary 
heart disease. 
Of those main forms, the first two were practiced most – these were most prominent 
longitudinal studies on TABP and health. The issue of TABP components was dealt with 
less extensively, similarly like the explanation mechanisms for plausibility of causal 
association. The modification of TABP has been mainly done only by one of the construct 
authors, who showed that the TABP is modifiable – the intervention in terms of counseling 
can lead to decrease of cardiovascular risk in about 5 years [Friedman et al. 1986]. 
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Based on the review of original studies on TABP it can be summarized that the 
associations between TABP and health outcomes depend on many factors. On the one 
hand, these are population-specific indicators, such as age group, gender, prior or current 
diseases. On the other hand, there are different measurement techniques to evaluate the 
extent of TABP as a personality trait. 
Another very important aspect is that there are many psychological factors that can 
trigger the negative effects on health. Some of them (such as hostility) could be in causal 
chain between TABP and premature death and possibly can be regarded as components of 
TABP, though non necessarily specific ones. Simultaneously, there exists variety of 
personal features within every individual at the same time which means that even a person 
with disease-prone aspect of personality can have or develop the traits or behaviors that 
lead to protective effects. 
In general it can be noted that possible mechanisms for associations of TABP and health 
have been proposed, but the true mechanism is still under question. It can happen so that it 
is not the TABP which triggers the negative physiologic reactions in individual, but some 
other related psychological factors – overt (such as hostility) or hidden (stress or dissonance 
between personal strivings and society’s expectations or sense of social desirability) ones. 
It should be noted that the studies on TABP have omitted the cultural aspects, they had 
not provided epidemiological data on TABP across populations and subgroups, and did 
not count for other psychological traits. All this can be relevant in the cultural perspective 
of the Type A phenomenon, which is a Western culture-bound syndrome, as a variant of 
character neurosis – “as the normal madness of our culture” [Julkunen 1988]. The TABP is 
embodying many of the cultural values of an industrial, capitalist society, where 
competition, ambition, materialism, and time-urgency of rush hours and deadlines are all 
part of daily life [Helman 2000]. Furthermore, this model of stressful behavior also 
encompasses some of the contradictions within cultural values of Western societies, and the 
Type A individual is the living embodiment of those contradictions. On the one hand, the 
individuals displaying the Type A show marked aggressiveness, ambition and competitive 
drive, which usually are not considered as very good features in personal relations. Such 
people are work-oriented and ‘workaholic’, preoccupied with deadlines and chronically 
impatient [Friedman & Rosenman 1959]. On the other hand, modern Western industrial 
society encourages the development of TABP traits by rewarding them: those who exhibit 
them often become successful executives, professionals, politicians, managers, technocrats, 
and salesmen. However, these rewards often involve constant anxiety about failure, 
demotion or loss of control. Appels [1972] saw the Type A as a personality who cannot 
manage or handle the pressure of industrialized, fast-moving and achievement-oriented 
society and who, by this very failure, shows the characteristics of this society in an 
excessive way. In his study of 22 societies he found that the mortality rate from CHD was 
positively correlated with a cultural emphasis on the need for achievement in the societies. 
It can be argued that this paradox of values – that some forms of antisocial behavior are 
being constantly rewarded by the society – is symbolically resolved when the Type A 
individual is ‘punished’ by suffering a heart attack, and emerges from the hospital as a 
chastened, fragile and less aggressive Type B [Helman 2000]. Similarly, Carroll [1995] 
suggested that since it is not a Type A individuals that have an increased risks but rather 
their environments that elicit the behavior pattern in them, this means that sociocultural 
aspects can have very important implications for the effects of TABP on health. 
Finally, Alspach [2004] stated: “Rather than being subjected to endless television 
commercials showing excited middle-aged people bragging about how they lowered their 
bad cholesterol levels, we could look forward to endless commercials displaying calm 
young people bragging about how they eradicated road rage (job rage, air rage, parking lot 
rage, and the like) from their lives”. 
Regardless of many studies conducted this far, there is still no comprehensive 
psychological theory of coronary-prone (or disease-prone) personality and behavior, 
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possibly because the history of TABP research has been characterized by non-theoretical 
and over-empirical approach [Julkunen 1988]. Intercultural comparisons are restricted due 
to the lack of comparable data across countries, decades, and populations. 
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3 Aims of study 
The main aim of this study was to examine with multiple Type A measures, reasonably 
large population-based sample, broad set of covariates, and long prospective follow-up 
design, whether the Type A behavior pattern (TABP) and cynicism associate with 
premature cardiovascular and non-cardiovascular mortality in middle-aged-to-aging 
Finnish men. 
The objectives (specific aims) of the study: 
1) to examine the association between the Type A and cardiovascular mortality; 
2) to examine the association between the Type A and cardiovascular mortality 
depending on subjects cardiovascular history at baseline; 
3) to examine the association between the Type A and non-cardiovascular mortality; 
4) to examine the association between the cynicism and mortality; 
5) to examine the effect of measurement scales and follow-up time on associations 
between the Type A and mortality. 
 
Hypotheses of the study: 
• there exists an association between the Type A and mortality as assessed with 
different tools; 
• the association of the Type A and mortality depends on subjects cardiovascular 
history at baseline; 
• there exists an association between the cynicism and mortality; 
• the association of the Type A and mortality depends on measurement scale and 
follow-up time. 
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4 Methods 
4.1 DESCRIPTION OF KUOPIO ISCHEMIC HEART DISEASE RISK FACTOR 
STUDY 
This study is based on the data from the Kuopio Ischemic Heart Disease Risk Factor Study 
(KIHD). It is an ongoing population-based study investigating risk factors for chronic 
diseases and focusing mainly on cardiovascular diseases. This longitudinal study was 
designated to investigate the previously not established risk factors for ischemic heart 
disease and carotid atherosclerosis in a population-based sample of middle-aged Finnish 
men, residing in the town of Kuopio and its surroundings [Salonen 1988]. 
The study participants completed 3 questionnaires that were mailed to their homes. 
Then they were invited to the study center for structured clinical examination where such 
samples as a blood were taken and physical tests were performed. Research nurse 
interviewed the participants during the examination. 
The study cohort was record-linked with the National Death Registry. Due to complete 
follow-up system of the Finnish population, there are no losses to follow up [Toriola et al. 
2008]. Compared to other studies, the KIHD study has a more comprehensive assessment of 
psychosocial data including over 600 questionnaire items [Miller et al. 1995]. 
The author of present work has received from the KIHD database the data on variables 
of interest and has independently performed all analyses of this work. 
4.2 SUBJECTS 
Sampling started with the 3,433 eligible non-institutionalized men aged 42–43, 48–49, 54–55, 
or 60–61 years who resided in the town of Kuopio or surrounding rural communities in 
Finland. It was a random sample of the middle-aged male population. Of the 3,433 eligible 
men 198 were excluded because of death, serious disease or migration away from the area 
[Lynch et al. 1996]. The rest of eligible sample (3,235 in total) were invited to participate in 
the study and 2,682 agreed to participate (response rate 82.9% of all invited men). There 
have been found no marked sociodemographic differences between participants and non-
participants [Lakka & Salonen et al. 1992]. The baseline examinations were conducted 
between March 1984 and December 1989. 
At baseline, the subjects were recruited in two waves. The Cohort 1 comprised of 1,166 
men 54–55 years old that were examined from March to December 1986. The second wave 
or Cohort 2 was examined between August 1986 and December 1989 comprising an age-
stratified sample of 1,516 men aged 42–43, 48–49, 54–55, and 60–61 years. There were no 
systematic differences between the two waves of recruitment other than the different age 
distribution. The age range within age groups did not exceed 1.5 years (Table 1). 
Only a certain number of men could be examined per day because the physical 
examinations and biological measurements were quite extensive. Therefore, until year 2009 
(latest data available) some men have been in the follow-up for about 20 years, and some 
for up to 26 years. The study has not ended yet and the follow-up is still ongoing and will 
continue through national health registries. 
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Table 1. Age distribution of Kuopio Ischemic Heart Disease Risk Factor Study sample (N=2,682) 
 
Age group n % of sample Mean Median SD Min Max 
42-43 years 334 12.5 42.5 42.5 0.30 42 43.42 
48-49 years 358 13.3 48.5 48.5 0.30 48 49.25 
54-55 years 1592 59.4 54.4 54.4 0.23 54 55.5 
60-61 years 398 14.8 60.6 60.6 0.33 60 61.33 
 
4.3 MEASUREMENTS 
4.3.1 Type A and cynicism measures 
For evaluation of exposure variables, the Type A scales and Cynical Distrust Scale for 
hostility (cynicism) were used. The validity of original scales (based on Cronbach’s alpha) 
was not verified since it has been checked elsewhere (in previous studies) and were chosen 
as measurements of TABP and related phenomena. The items of original questionnaires 
were not analyzed. At the baseline examinations participants completed the detailed self-
reported questionnaires. The KIHD study includes four Type A scales and a short version 
of Cook-Medley Hostility Inventory scale [Miller et al. 1995], that is called Cynical Distrust 
Scale. The reliability and validity of these scales have been established in Finland 
[Greenglass & Julkunen 1989]. 
Finnish Type A Scale (FINT) is a 15 items scale reflecting the personality features such as 
time urgency, impatience, competitiveness, efficiency, and inability to relax [Järvikoski & 
Härkäpää 1987]. It has been shown to differentiate the persons with coronary heart disease 
(CHD) symptoms from healthy controls. The scale includes questions about ease of 
irritation, hurrying others along, and peacefulness of personal character. 
Bortner Short Rating Scale (BRS) consists of 14 bipolar pairs of descriptors, letting the 
subject to choose the place between the two extremes on every item [Bortner 1969]. The 
questionnaire asks the responder to assess current temper. 
Framingham Type A Behavior Pattern Scale (FTAS) consists of 10 self-reported items 
and was derived from the analysis of the Framingham Heart Study (FHS) [Haynes et al. 
1978]. Five items reflect characteristics of the TABP (hard-driving and competitive, pressed 
for time, bossy and dominating, need to excel, eating too quickly) and response format is 
describing person’s opinion as ‘not at all’, ‘somewhat’, ‘fairly well’, ‘very well’ (scored 1 to 
4, respectively). Another five items reflect work orientation and time pressure as is often 
associated with TABP. For them a response format is ‘agree’ or ‘disagree’ (scored 1 or 0, 
respectively). In general, the Framingham scale asks whether subjects would describe 
themselves as bossy or dominating. 
Jenkins Activity Survey (JAS) was constructed as a questionnaire [Jenkins et al. 1979] 
equivalent to the Structured Interview (SI) and was developed in an attempt to duplicate 
the clinical assessment of TABP by employing an objective psychometric procedure. The 
individuals displaying the Type A are characterized by extremes of competitiveness, 
striving for achievement and personal recognition, aggressiveness, haste, impatience, 
explosiveness and loudness in speech. All these characteristics are the ones which the JAS 
attempts to measure. The scale comprises of 21 items. The scale agrees with the SI on 
judgment about TABP in 70–73% of cases [Jenkins & Zyzanski 1980], and was formed based 
19 
 
 
on the data from Western Collaborative Group Study. Similarly like the Bortner scale, JAS 
asks the respondent to evaluate current temper, but additionally asks about temper at 
younger ages. 
Multiscale Assessment (MSA) was derived as a new instrument constructed for this 
study solely. The MSA has been constructed as a response to relatively moderate 
intercorrelations of the original Type A scales observed in the study (this implies certain 
differences in the constructs measured by those scales). The MSA was calculated by 
categorizing the Type A into 3 groups (as high, medium, and low, referred to as Type A, 
Type A/B, Type B) based on measurements of the four original Type A scales used in this 
study – FINT, BRS, FTAS, and JAS. The MSA was divided to tertiles. The point of interest 
was to show the risk in comparing each tertile with the first tertile as a reference category 
(referring to the Type B). 
The process of MSA calculation was performed in the following manner: four original 
scales (FINT, BRS, FTAS, and JAS) were all categorized into tertiles: 
• 1st – low level (Type B), 
• 2nd – medium level (Type A/B), 
• 3rd – high level (Type A). 
Further it was counted on how many of those 4 scales the subject has the highest level 
(upper tertile). This sum (or MSA score) was from 0 (none of 4 original TABP scales showed 
the highest level of Type A) to 4 (every of the 4 original TABP scales showed the highest 
level). The sum of 2–4 was considered to be Type A, the sum of 1 – Type A/B, and the sum 
of 0 – Type B (cut-off points based on distribution of MSA score) (Figure 1). 
 
 
Figure 1. Construction of Multiscale Assessment based on the original Type A scales 
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The difference of the original and multiassessment scales in analyses is that the original 
scales were categorized into quartiles while the newly developed scale was based on 
categorization into tertiles (for more straight interpretation, i.e. Type A, Type A/B or Type 
B). 
Cynical Distrust Scale is a derivative of the Cook-Medley Hostility Inventory (CMHI). 
The latter is 50 items (true-false response) scale and has been derived from the Minnesota 
Multiphasic Personality Inventory (MMPI), initially designed as a measure of student 
rapport among teachers [Cook & Medley 1954]. The 8-item subscale was found to correlate 
0.77 with the full Cook-Medley scale in a Finnish sample and appears to be a reliable and 
valid scale in Finland [Greenglass & Julkunen 1989]. This scale was factor-analytically 
derived from the Cook-Medley Hostility Scale. Cronbach’s alpha for the Cynical Distrust 
Scale was 0.81, indicating good internal consistency. A low score on this scale suggests that 
the respondent believes that people are dishonest and only care about themselves [Miller et 
al. 1995]. In our study, cynicism (or hostility) was assessed from the shortened version of 
the CMHI scale – Cynical Distrust Scale (CDS) [Everson et al. 1997]. Previous research with 
CDS has shown it to be a reliable, valid, and more specific measure of cynicism and distrust 
than the 50-item Cook-Medley Hostility Scale [Greenglass & Julkunen 1989]. Additionally, 
the Cynical Distrust Scale was significantly associated with mortality in earlier analysis of 
the KIHD participants [Everson et al. 1997]. 
Items on the Cynical Distrust Scale include the following: 
• I think most people would lie to get ahead. 
• Most people inwardly dislike putting themselves out to help other people. 
• Most people make friends because friends are likely to be useful to them. 
• It is safer to trust nobody. 
• No one cares much what happens to you. 
• Most people are honest chiefly through fear of being caught. 
• I commonly wonder what hidden reasons another person may have for doing 
something nice to me. 
• Most people will use somewhat unfair means to gain profit or an advantage rather 
than lose it. 
Response options were altered from the original true-false format of scale to a 4-point 
Likert scale as follows: 0 = completely agree, 1 = somewhat agree, 2 = somewhat disagree, 
and 3 = completely disagree. This format allowed for greater variance and a nearly normal 
distribution of scores. Items were scored reverse and summed to obtain a CDS score 
ranging from 0 to 24. 
All original scales were divided into quartiles (25th, 50th and 75th percentiles) for the 
analyses. 
4.3.2 Covariates 
The estimates between the exposure and outcome were based on survival models that 
included a set of covariates. As covariates, certain biological, clinical, and social variables 
were used, majority of which were considered as conventional risk factors for many chronic 
diseases and therefore having a potential effect on exposure-outcome associations in our 
study. They were chosen based on the previous literature, looking for the covariates that 
are most commonly confounding the associations between TABP and cardiovascular 
diseases (CVD) or other mortality. Some covariates were categorized compared with the 
original data of the study. The full set of covariates consisted of 10 or 11 variables in 4 
subgroups, depending on the outcome (Table 2): 
1) Age, 
2) Biological covariates, 
3) Socioeconomic covariates, 
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4) Prior history of CVD (for CVD mortality only). 
 
Table 2. Covariates used in adjusted survival analysis 
 
Type # Covariate Variable type 
Label in the 
database 
Age 1 Age group Ordinal agegroup 
Biologic 2 Physical activity, kcal/day Scale licalc2 
3 Smoking, cigarettes × years Scale cigyears 
4 BMI, kg/m2 Scale bmi 
5 Alcohol consumption, g/week Scale algrwk2 
6 HDL/LDL ratio Scale hdlldl 
7 SBP, mm Hg Scale systka 
Socioeconomic 8 Occupation (3 categories) Ordinal occ3 
9 Education (4 categories) Ordinal educ4 
10 Income (5 categories) Ordinal hinc5 
CVD history 11 Prior history of CVD Nominal cvd 
Note: BMI – body mass index, HDL – high density lipoproteins, LDL – low density lipoproteins, SBP – 
systolic blood pressure, CVD – cardiovascular diseases. 
 
1. Age. The distribution of age groups was described in subsection Subjects (see 
Methods). 
2. Biological covariates. Biological covariates included behavioral variables (physical 
activity, smoking, and alcohol consumption) as well as anthropometric (body mass index) 
and physiological-biochemical (HDL/LDL ratio and systolic blood pressure) indicators. 
Biological covariates were included into calculations as continuous variables (Table 3). The 
distributions of socioeconomic covariates within categories of the exposure scales are 
presented in Appendices. 
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Table 3. Biological covariates 
 
Covariate Mean SD 
Percentiles 
0 25th 50th 75th 100 
Physical activity, kcal/day 140.4 175.67 0 29 83 190 2493 
Smoking, cigarettes × years 168.5 335.26 0 0 0 224 3485 
BMI, kg/m2 62.902 3.6049 17.10 24.5 26.5 28.9 48.55 
Alcohol consumption, g/week 76.2 138.49 0 6 31 93 2853 
HDL/LDL ratio 0.347 0.1434 0.09 0.25 0.32 0.41 1.99 
SBP, mm Hg 134.3 17.08 88 123 132 144 221 
Note: BMI – body mass index, HDL – high density lipoproteins, LDL – low density lipoproteins, SBP – 
systolic blood pressure. 
 
Leisure time physical activity was assessed from a 12-month history, modified from the 
Minnesota Leisure Time Physical Activity Questionnaire [Lakka et al. 1994]. The checklist 
included the most common leisure-time physical activities of middle-aged Finnish men, 
selected on the basis of a previous population study in Finland [Mälkiä et al. 1988]. For each 
activity performed, the subjects were asked to record the frequency (number of sessions per 
month), average duration (hours and minutes per session), and intensity (from 0 for 
recreational activity to 3 for competitive, strenuous exercise). Physical activities were 
expressed in metabolic equivalents (MET) [Lakka et al. 1994], where one MET corresponds 
to an energy expenditure of approximately 1 kcal per kilogram body weight per hour. In 
our analyses the equivalent was recalculated for a day (MET × 24). 
Blood samples were drawn after fasting and abstinence from smoking for 12 hours, 
abstinence from alcohol for 3 days, and abstinence from using analgesics for 7 days [Lynch 
et al. 1996]. After the subject rested supine for 30 minutes, blood was drawn without a 
tourniquet, using Terumo Venoject VT-100 PZ vacuum tubes (Terumo Corp., Tokyo, 
Japan). Lipoproteins were separated from unfrozen plasma within 3 days of sampling. High 
and low density lipoprotein fractions were separated from fresh plasma by using both 
ultracentrifugation and precipitation. The cholesterol content of all lipoprotein fractions 
and serum triglycerides was measured enzymatically (CHOD-PAP cholesterol method and 
GPO-PAP triglyceride method, Boehringer Mannheim, Germany) on the day after the last 
spin. Average systolic blood pressure was also used in analyses. Resting blood pressure 
was measured between 8:00 and 10:00 AM on the first examination day by one nurse with a 
random-zero mercury sphygmomanometer. The measuring protocol included, after a 
supine rest of 5 minutes, three measurements in supine, one in standing, and two in sitting 
position with 5-minutes intervals. The mean of all six systolic pressure values was used in 
the present analyses as the systolic blood pressure [Salonen et al. 1992]. Body mass index 
(BMI) was calculated by dividing the subject’s weight by the square of his height (kg/m2) 
[Lynch et al. 1996]. Life-long exposure to smoking (in cigarette pack years) was estimated as 
a product of the number of smoking years and the number of tobacco products smoked 
daily until the time of baseline examination [Salonen et al. 1992]. ‘Years smoked’ were 
defined as the sum of years of smoking regardless of when smoking had started, whether 
the subject had stopped smoking, or whether it had occurred continuously or during 
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several periods. Alcohol consumption, measured in grams per week, was assessed by self-
administered questionnaire from dietary recording for a 4-day period and also for the 
previous 12 months [Ihanainen et al. 1989]. The questionnaire was the Nordic Alcohol 
Consumption Inventory, which contains 15 items [Salonen et al. 1992]. 
3. Socioeconomic covariates. There were 3 socioeconomic covariates included to 
survival analyses. These were self-reported indicators. At baseline examinations, 
participants completed detailed questionnaires that included items on personal and 
household income, education, lifetime occupation, housing tenure, material living 
conditions etc. We included the personal income, since previous analyses revealed that it 
was the strongest predictor of mortality in this group of men [Lynch et al. 1994], and similar 
findings were obtained for the other indicators of socioeconomic status, such as education 
and occupation [Lynch et al. 1996]. 
Various occupations of participants were grouped into 3 categories: 
1) Farmers – men mainly active in rural areas on farming, comprising 16.2% of study 
sample; 
2) Blue-collar workers – manual occupations such as workers in industry, construction, 
mining etc., comprising 44.3% of study sample; 
3) White-collar workers – non-manual occupations such as management, work at office, 
etc., comprising 39.6% of study sample. 
The education level was based on the highest level of education degree achieved. The 
subjects were classified into 4 groups: 
1) Less than elementary education (10.0%) – part of elementary school; 
2) Elementary education (48.1%), usually 4–8 years – elementary school (primary 
education) with or without part of junior high school; 
3) Secondary education (35.1%), usually 9–12 years – elementary school with vocational 
school (at least 1 year) / junior high school with or without part of senior high school / 
junior high school with vocational school (at least 1 year); 
4) Higher education (6.8%), 12 years or more – senior high school with graduation / 
senior high school with academic degree / academic degree (diploma of college or 
university). 
In the category 4, those with high school diploma and those who continued for further 
college or university level education were combined to one category, since the proportion 
of men with tertiary education was not very high in those cohorts, unlike among the 
younger age groups in Finland. 
The income of study participants was based on a reported taxable personal income of 
earnings from the year preceding the baseline data collection. This was expressed in 
Finnish marks being the national currency at that time. For further analyses the income 
distribution was divided into quintiles: 
1) 0 to 37,000 marks (19.7%); 
2) 38,000 to 59,000 marks (20.0%); 
3) 59,235 to 77,000 marks (20.0%); 
4) 78,000 to 106,000 marks (20.3%); 
5) 107,000 to 600,000 marks (20.0%). 
4. Prior history of CVD. For survival calculations of CVD mortality only, additional 
covariate was included – the history of prior CVD. The history of CVD implied some of the 
following: ischemic heart disease, coronary by-pass, cardiac insufficiency, cardiomyopathia, 
other coronary disease, stroke, claudication, arrhythmia, or other heart disease. Prior 
history of CVD was treated in survival analyses in two ways: 
1) As covariate, resulting in one effect estimate; 
2) As effect modifier, resulting in two separate effect estimates depending on prior 
status. 
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4.3.3 Outcome variables 
The outcome variables included mortality – separately CVD and non-CVD. Additionally, 
CVD mortality trends were calculated separately for subjects with and without CVD 
history at baseline: 
• CVD mortality in all study subjects; 
• CVD mortality in subjects without CVD history at baseline; 
• CVD mortality in subjects with CVD history at baseline; 
• non-CVD mortality in all study subjects. 
The outcome was described in terms of status (dichotomous – ‘dead’ or ‘alive’) and the 
time of the follow-up. All-cause mortality and cardiovascular mortality were ascertained by 
linkage to the National Death Registry, which is maintained for all citizens of Finland. 
Classification of death was based on the underlying cause, reviewed at the National Center 
of Statistics of Finland [Lynch et al. 1996]. The causes of death were classified according to 
the International Classification of Diseases, ninth revision (ICD-9, the one used when the 
study launched). The codes for cardiovascular diseases were 390–459. 
Mortality during follow-up. Until the end of 2009 (the last data available) the average 
follow-up time of study subjects was 7,087 ± 2,258 days (or 19.4 ± 6.18 years). The whole 
follow-up has counted 52,042 person-years. The death rate during this period was 36.0%, 
and almost half of all deaths (46.8%) were related to cardiovascular diseases (coronary heart 
disease, stroke and others), cancer being the second cause of death (27.1% of all deaths; 
Table 4). 
 
Table 4. Causes of death in the Kuopio Ischemic Heart Disease Risk Factor Study population (until 2009) 
 
Mortality ICD-9 code Subjects without CVD history 
at baseline (n=1,666) 
Subjects with CVD history 
at baseline (n=1,016) 
Total (n=2,682) 
n % N % n % 
All causes  490 29.4 476 46.9 966 36.0 
– CVD 390–459 184 11.0 268 26.4 452 16.9 
–– CHD 410–414 116 7.0 199 19.6 315 11.7 
–– Stroke 430–438 32 1.9 33 3.2 65 2.4 
– Non-CVD  306 18.4 208 20.5 514 19.2 
–– Cancer 140–239 161 9.7 101 9.9 262 9.8 
–– Injury 800–999 54 3.2 31 3.1 85 3.2 
–– Suicide 950–959 17 1.0 7 0.7 24 0.9 
Note: CVD – cardiovascular diseases, CHD – coronary heart disease, ICD – International Statistical 
Classification of Diseases and Related Health Problems. 
 
The cumulative mortality was increasing steadily throughout the whole follow-up, 
almost in a linear manner and totaling to 966 deaths at 26 years of follow-up (Figure 2). 
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Note: CVD – cardiovascular diseases. 
Figure 2. Cumulative mortality and causes along the follow-up in the Kuopio Ischemic Heart Disease Risk Factor Study 
4.4 STATISTICAL ANALYSES 
Descriptive statistics were presented as means and proportions (in percents). Continuous 
variables were described by arithmetic mean ± standard deviation. Statistical significance 
level was set at 95%. The data analyses were performed using the “SPSS for Windows 17.0” 
statistical package. 
Correlation analysis about measurement scales (categorization) was performed by 
calculating Spearman correlation coefficient and kappa coefficient. Based on central limit 
theorem and having large sample size, parametric methods were used despite skewed 
distributions of some variables. The theorem states that if an infinite number of random 
samples of equal sizes are selected from a population, the sampling distribution of the 
sample means will approach a normal distribution as sample size approaches infinity, 
regardless of variable’s distribution. The population may be non-normal, yet repeated 
sampling will theoretically generate normal sampling distribution [Argyrous 2008, p. 210]. 
Comparison of means for the age groups was performed using one-way ANOVA. 
Cox proportional hazards model. For the survival data analysis the Cox proportional 
hazards model was applied [Cox 1972]. It considered 4 outcome categories and the 
calculations have been performed separately for every outcome group (CVD mortality in 
total sample, subsamples of subjects with and without CVD history at baseline, and non-
CVD mortality in total sample). The covariates in the model included age group, 
socioeconomic factors, and biological factors. CVD history at baseline as a covariate was 
included only to CVD mortality calculations for the total sample. The risk of death in 
survival analyses was expressed in hazard rate ratios (HRR). 
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4.5 ETHICS 
The Research Ethics Committee of the University of Kuopio has approved the study 
protocol, and each participant gave a written informed consent to participate in the KIHD. 
The author of present study has agreed to the proper use and confidentiality of these data. 
 
27 
 
 
 
5 Results 
5.1 TABP AND CDS MEASUREMENTS 
The main indicators of scales distributions including percentiles are presented in Table 5, 
and the distributions according to age group – in Figure 3. The average score in Finnish 
Type A Scale (FINT) was 22.4 ± 4.93 pts (highest among 48–49 years old men), in Jenkins 
Activity Survey (JAS) 158.7 ± 57.87 pts (highest among 48–49 years old men), in Bortner 
Rating Scale (BRS) 14.6 ± 3.12 pts (highest among 42–43 years old men), in Framingham 
Type A Scale (FTAS) 12.9 ± 3.57 pts (highest among 42–49 years old men), and in Cynical 
Distrust Scale (CDS) 12.7 ± 4.20 pts (highest among 60–61 years old men). Of note, in the 
Type A behavior pattern (TABP) scales the highest mean scores were in younger generation 
of study participants, while in the cynicism scale – among older men. 
 
Table 5. Distributions of the Type A and cynicism scales in the study sample (N=2,682) 
 
Scale Mean SD 
Percentiles 
0 25th 50th 75th 100th 
FINT 22.4 4.93 6 19 22 25 43 
JAS 158.7 57.87 42 112 154 201.5 336 
BRS 14.6 3.12 2 13 14 17 27 
FTAS 12.9 3.57 5 10 13 15 25 
CDS 12.7 4.20 1 10 13 15 24 
Note: FINT – Finnish Type A Scale, JAS – Jenkins Activity Survey, BRS – Bortner Rating Scale, FTAS – 
Framingham Type A Scale, CDS – Cynical Distrust Scale. 
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Note: FINT – Finnish Type A Scale (P=0.140), JAS – Jenkins Activity Survey (P=0.484), BRS – Bortner Rating 
Scale (P<0.001), FTAS – Framingham Type A Scale (P=0.091), CDS – Cynical Distrust Scale (P=0.002). 
 
Figure 3. Mean values of the Type A and cynicism scales across age groups in the study sample (N=2,682) 
 
The scales of TABP showed moderate intercorrelations (correlation coefficient ranging 
from 0.32 to 0.50; Table 6) which were all highly statistically significant (P<0.001). The 
highest correlation was found between the FINT and FTAS scales. Comparing cynicism 
with the Type A, the Cynical Distrust Scale showed no correlation with TABP scales where 
the correlation was not exceeding r=0.15. 
The categorization of scales showed lower inter-scale agreement than correlation, with 
kappa coefficient ranging from 0.13 to 0.22. Like with the correlation, the best agreement 
between two scales was found for the Finnish and Framingham scales. Cynicism scale had 
almost no agreement with TABP scales (kappa very close to zero; Table 6). 
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Table 6. Intercorrelations of the Type A and cynicism scales in the study sample (N=2,682) 
 
Scale Coefficient FINT JAS BRS FTAS CDS 
FINT 
r 
– 
0.432 0.354 0.505 0.146 
κ 0.182 0.133 0.222 0.063 
JAS 
r 0.432 
– 
0.374 0.462 -0.005 
κ 0.182 0.157 0.172 0.011 
BRS 
r 0.354 0.374 
– 
0.325 -0.044 
κ 0.133 0.157 0.137 -0.006 
FTAS 
r 0.505 0.462 0.325 
– 
0.074 
κ 0.222 0.172 0.137 0.025 
CDS 
r 0.146 -0.005 -0.044 0.074 
– κ 0.063 0.011 -0.006 0.025 
Note: FINT – Finnish Type A Scale, JAS – Jenkins Activity Survey, BRS – Bortner Rating Scale, FTAS – 
Framingham Type A Scale, CDS – Cynical Distrust Scale. 
 
Since the scales that are supposed to correlate among each other (since they measure the 
same construct) did it only moderately, a new score for the TABP as a summary of all four 
original scales was constructed. The distributions between this derivative scale (Multiscale 
Assessment or MSA) and the original scales are presented in Table 7. The correlations of 
MSA with the original ones stayed at levels of r=0.65 (except BRS, where r=0.54). 
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Table 7. Categorization of the original Type A scales: distributions and correlations with Multiscale Assessment 
 
Scales Quartiles Multiscale Assessment r 
# n 1st tertile 
(n=1,154) 
2nd tertile 
(n=656) 
3rd tertile 
(n=872) 
Finnish Type A Scale 1st 625 455 137 33 0.650 
2nd 591 340 167 84 
3rd 539 156 185 198 
4th 548 0 83 465 
Jenkins Activity Survey 1st 668 517 122 29 0.665 
2nd 643 388 173 82 
3rd 655 196 224 235 
4th 655 0 132 523 
Bortner Rating Scale 1st 942 629 199 114 0.538 
2nd 386 201 120 65 
3rd 856 262 255 339 
4th 424 0 71 353 
Framingham Type A Scale 1st 677 509 126 42 0.652 
2nd 881 487 265 129 
3rd 470 102 166 202 
4th 589 0 92 497 
 
5.2 TABP AND MORTALITY 
Since there were many calculations related with exposure-outcome associations, there 
could be many tables presented. For simplicity, the results are presented in Figures. For 
precision, the numbers are presented in Appendices, where hazard rate ratios and P-values 
are presented in detail. 
The information is organized according to exposure categories (TABP and CDS scales) 
and presented depending on the outcome. Description of results covers not only the 
statistically significant findings, but the trends as well (based on actual differences between 
the groups rather than P-values only). 
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5.2.1 Finnish Type A Scale 
The Finnish Type A Scale showed moderately inverse association between TABP and 
cardiovascular mortality. However, the pattern of relationship slightly differed depending 
on the baseline CVD status (prior history of disease). The 4th quartile was associated with 
decreased CVD mortality in later years of follow-up and increased non-CVD mortality in 
earlier years (Figure 4). 
In subjects without CVD history at baseline, the risk of CVD death almost during the 
whole follow-up was about HRR=1.00 for the 3rd quartile, HRR>1.00 for the 2nd and 
HRR<1.00 for the 4th. The only statistically significant finding was for the 4th quartile at 26 
years (HRR=0.50). For the men with prior CVD the survival pattern was different – starting 
from 11 years, non-reference groups consistently tended to have lower risk than the 1st 
quartile. However, statistically significant difference was observed only at 26 years and 
only for the 4th quartile (HRR=0.63). The mortality from cardiovascular diseases in total 
sample of subjects was showing an inverse association between mortality and TABP. Here, 
the statistically significant findings were detected also for the 4th quartile, but already after 
21 years of follow-up (HRR=0.64), not only after 26 years (HRR=0.59). The best survival was 
observed in the 4th quartile, while the 2nd and the 3rd quartiles were closer to the reference 
group. 
Considering non-CVD mortality, the Type A seemed to be a risk factor, however, more 
in earlier than in later years of follow-up. Here the highest risk was found for the 4th 
quartile and was statistically significant until 16 years of follow-up (HRR=2.79 at 6 years, 
HRR=2.09 at 11 years, and HRR=1.45 at 16 years). Other quartiles differed from the 1st 
quartile not significantly, except the 3rd quartile at 21 years (HRR=0.70). The risk differences 
among the quartiles in latest years were decreasing, showing very similar non-CVD death 
risks. 
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5.2.2 Jenkins Activity Survey 
The analysis of Jenkins scale showed weaker associations between TABP and subsequent 
mortality compared to the Finnish Type A scale. Regarding CVD mortality, the risk partly 
depended on baseline status of CVD history in analyses up to 11–16 years of follow-up, but 
not later. The 3rd and the 4th quartiles seemed to be associated with decreased CVD and 
non-CVD mortality (Figure 5). 
The risk for CVD mortality in subjects without CVD history at baseline decreased until 
11 years of follow-up and then started to approach the reference level for all non-reference 
categories. For subjects with CVD history at baseline the trends were similar, except that 
non-reference categories were steadily approaching the 1st quartile, while the 4th quartile 
was almost consistently below the reference level. However, regardless of all that, the 
trends between CVD mortality and TABP measured by JAS were statistically non-
significant, even though at 26 years CVD mortality in total sample was hinting to dose-
response relationship. No statistically significant differences were detected throughout the 
whole follow-up. 
Non-CVD mortality and TABP as measured by JAS in the study population were 
similarly associated like CVD mortality in subjects without CVD history at baseline, though 
it showed slightly more inverse associations. However, statistically significant differences 
were observed only for the 3rd quartile after 16 years (HRR=0.68) and 21 years (HRR=0.73). 
All other differences were non-significant. 
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5.2.3 Bortner Rating Scale 
Bortner Rating Scale showed some associations between TABP and mortality. This scale 
consistently showed the lowest mortality risk for the 2nd quartile from early stages of 
follow-up, though non-significant (all findings related with BRS were statistically non-
significant). The differences between the quartiles were smaller in later stages of follow-up, 
especially concerning non-CVD mortality. The 4th quartile seemed to have the associations 
with mortality more dependent on CVD history at baseline than the other quartiles (Figure 
6). 
CVD mortality in subjects without prior CVD history was mostly deviating from the 
reference level after 16 years of follow-up (HRR=1.71) – in all other analyzed years, the risk 
estimates were quite similar, except the variation after 6 years (very low risks for the 2nd 
and the 3rd quartiles at levels of HRR=0.30). For the subjects with prior CVD, the risk 
estimates did not vary much depending on the duration of follow-up. Likewise, the risk of 
CVD death in total sample was also similar among the quartiles and showed no dose-
response relationships. 
Non-CVD mortality trends varied depending on the quartile. The risk of the 2nd quartile 
was steadily increasing from HRR=0.64 at 6 years to HRR=1.07 at 26 years, while the risk of 
the 4th quartile had decreasing trend from HRR=1.58 to HRR=1.00 during the same period, 
while the 3rd quartile had also decreasing trend, though not so strongly expressed like the 
4th quartile. Nevertheless, all these trends were statistically non-significant and did not 
reveal the dose-response relationship. 
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5.2.4 Framingham Type A scale 
The Framingham Type A Scale showed the findings that were dependent on the baseline 
status of study subjects. Here, for Type A men without CVD history the risk was decreasing 
throughout the whole follow-up (for the 4th quartile from HRR=3.01 after 6 years to 
HRR=0.78 after 26 years), while for the men with CVD history slightly increasing trends 
were prevailing (from HRR=0.75 to HRR=0.95 during the same period) (Figure 7). 
The 3rd and the 4th quartiles without CVD history at baseline had higher risk of CVD 
death in earlier years of follow-up but smaller risks in later years, from 16 years onwards. 
At 26 years of follow-up, the 4th quartile had statistically significantly lower risk of CVD 
death compared to the reference (HRR=0.55). Among the men with prior CVD, the risks 
across quartiles differed less than among men without prior CVD and no statistically 
significant differences were detected. Dose-response relationships were rare. 
Considering non-cardiovascular mortality, the 3rd quartile had consistently higher risks 
throughout the study, while the 2nd and the 4th quartile had partly increased risks, though 
the risks had decreasing trends during the follow-up. Non-CVD mortality associations with 
TABP as measured by Framingham scale showed that it is the 3rd quartile that has the 
highest risk for premature death. This was observed as a statistically significant finding 
during the whole study (from HRR=2.24 at 6 years to HRR=1.32 at 26 years), except at 16 
years. This quartile was the main obstacle for dose-response relationship. 
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5.2.5 Multiscale Assessment 
The Multiscale Assessment unlike other Type A scales had 3 categories instead of 4, but in 
common it shared the concept of reference category implying the least expressed Type A. 
The findings showed that the association between TABP and mortality depended on 
follow-up time (more in earlier than in later years) and on outcome, although the majority 
of associations were less expressed than in other scales. Statistically significant differences 
were not detected and dose-response relationships were inconsistent (Figure 8). 
The CVD mortality among the subjects without CVD history at baseline was higher than 
the reference for the 2nd tertile (HRR=1.12), but lower than the reference for the 3rd tertile 
(HRR=0.88) after 21 years of follow-up and onwards. In other years, the non-reference 
groups were showing mortality that was crossing the HRR=1.00 during the follow-up. 
Among the men with prior CVD at baseline, the CVD mortality was more consistent 
throughout the years with the 3rd category having the lowest risk of CVD death. In the 
estimates of CVD mortality in total sample the findings showed that up to 11 years the 
trends were following that of the men with CVD history, while in later years the trends 
were similar to that of the men without history of CVD. 
Non-CVD mortality associations with the Multiscale Assessment were found as not 
following dose-response curve. The risk for the 3rd category was very high at 6 years 
(HRR=1.71) with borderline significance, but this risk decreased during the follow-up 
gradually down to HRR=1.07 at 26 years. The 2nd quartile had the risk of non-CVD death 
very similar to that of reference category, ranging from HRR=0.92 to HRR=1.07. 
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5.3 CYNICISM AND MORTALITY 
The Cynical Distrust Scale unlike TABP scales showed relatively strong associations 
between the exposure and outcome. In majority of cases the cynicism (a construct measured 
by this scale) was consistently associated with higher risk of both CVD and non-CVD 
mortality, and this manifested differently depending on the CVD history at baseline. The 
CDS scale showed the most consistent and numerous statistically significant differences 
across the study. The 4th quartile in majority of cases was the one having the highest risk of 
death within analyzed period of follow-up (Figure 8). 
The CVD mortality among the men without CVD history was significantly higher 
especially in the 4th quartile, being above level of HRR=2.00 until 16 years and not lower 
than HRR=1.70 later. The medium quartiles were associated with CVD mortality not in a 
dose-response relationship, mainly due to outliers in the 2nd quartile during the early 
follow-up. Meanwhile, in individuals with CVD history at baseline different CVD mortality 
trends were detected. Here the risk for non-reference groups was increasing throughout the 
follow-up almost consistently. However, even though the risk for the 3rd and the 4th 
quartiles by latter half was higher than the reference (e.g. HRR=1.25 and HRR=1.18 at 26 
years, respectively), but no statistically significant differences were found during the whole 
follow-up. The CVD mortality calculations for the whole sample revealed that starting from 
11 years there was almost dose-response relationship observed, but statistically 
significantly higher risk was detected only for the 4th quartile (HRR=1.40 at 26 years). 
Regarding non-CVD mortality, the most obvious and consistent finding was that only 
the 4th quartile had a higher risk of death than the other quartiles of cynicism scale. 
However, this was not statistically significant and was at levels from HRR=1.15 to 
HRR=1.39. There was not so much dependence of cynicism-mortality association on the 
follow-up time. Of note, starting from 11 years onwards, the 2nd and the 3rd quartiles had 
lower than reference risks of non-CVD death. There were no statistically significant 
findings considering cynicism and non-cardiovascular mortality. 
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5.4 TYPE A COMPARED TO TYPE B 
Additional comparisons were made comparing the highest categories of different scales 
(the 4th quartiles for the original Type A or cynicism scales and the 3rd tertile for MSA) with 
reference categories (the 1st quartiles, meaning the Type B or no-cynicism). 
Evaluation of CVD mortality among individuals without prior CVD history showed that 
until 10 years of follow-up there were not so many well expressed associations between 
TABP or cynicism and mortality. The highest risk was observed for cynicism scale, while 
among the Type A scales there was only Framingham scale that showed similar levels of 
risk, though only in earliest stage of follow-up. Of note, the Framingham scale was more 
consistently following the trends of cynicism scale than any other TABP scale. Other TABP 
scales mostly showed inverse associations between TABP and CVD mortality. 
The CVD mortality among the men with CVD history at baseline showed no extreme 
values of risk. It was only the Bortner scale in early stages and cynicism scale in middle and 
late stages of the follow-up that showed an increased risk of death, while during the other 
periods (for other scales throughout the whole follow-up) the risk of CVD death for 
subjects with the highest levels on TABP scales was consistently lower compared to the 
Type B. 
The CVD mortality analysis in the total study sample showed that there exists an 
increased risk of CVD death for men with the highest levels of cynicism. Among TABP 
scales the majority showed inverse or no associations, especially in earlier stages of follow-
up. Of note, most consistent and most expressed inverse associations were observed for the 
Finnish and Jenkins scales. 
Non-CVD mortality showed the association patterns different from that observed in case 
of CVD mortality. The associations were consistently declining from early years when they 
all showed positive relationships – later they were declining and in some cases even 
crossing down to HRR<1.00 levels. The Finnish scale showed considerably stronger 
associations in early years compared to other scales, but declined to average levels by the 
middle of follow-up. The cynicism scale was following the trends of TABP scales. 
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6 Discussion 
The main aim of our study was to examine with multiple Type A measures, reasonably 
large population-based sample, broad set of covariates, and long prospective follow-up 
design, whether the Type A behavior pattern (TABP) associates with the premature 
cardiovascular and non-cardiovascular mortality in middle-aged-to-aging Finnish men. The 
study was unique in that it used four different original TABP scales and also used cross-
sections for survival analyses based on 6, 11, 16, 21, and 26 years of follow-up. This was the 
only study to apply so many TABP measures on the same individuals and such approach to 
survival analyses enabled to estimate the robustness of associations and dependence of 
them on the method of assessment and follow-up time. 
In our study we found that the TABP tends to be not associated or inversely associated 
with cardiovascular mortality among middle-aged and aging men. The inverse associations 
between TABP and cardiovascular mortality were rather more expressed among the men 
with cardiovascular history at baseline than without. Considering non-cardiovascular 
mortality it was found that the Type A associated mainly in earlier follow-up until 11 years, 
however, later follow-up showed slight or no risk effect of the Type A. This can suggest 
that there exists a certain window of follow-up that shows most remarkable associations 
between the exposure and outcome. 
In the study we also evaluated the cynicism (cynical distrust) as a potential risk factor to 
premature mortality, that is presumably a component of TABP. We found that cynicism 
seems to be associated with an increased risk of both cardiovascular and non-
cardiovascular mortality. 
In general it should be noted, that the associations between TABP and mortality strongly 
depend on the Type A scales that in turn show only moderate intercorrelations. Stronger 
associations were observed with the Framingham and Finnish than the Jenkins and Bortner 
scales, while the follow-up time was related with the strongest associations at 6–11 years of 
follow-up. 
The results of our study support the idea of the TABP as complex phenomenon which is 
related with ambiguous associations with mortality. Associations are dependent on 
measurement scales, follow-up time and health-related indicators such as cardiovascular 
disease (CVD) history of study participants. Finally, the associations partly depend on the 
definition of endpoints (outcomes). All these factors make the generalization and 
extrapolation of the study results quite complex. Nevertheless, such findings quite clearly 
support the idea that the TABP is not associated with health outcomes, or if it is – then only 
inconsistently and mostly depending on other sample- or study-related factors. Our study 
enabled us to make the statement based on various measurement scales and including 
conventional biological and social covariates which makes the results more robust. 
6.1 MAIN FINDINGS 
In our study, the associations between TABP and cardiovascular mortality were checked 
separately for subjects who had CVD history at baseline and who had not. The findings 
showed that the pattern of associations considerably depend on outcome measure and on 
baseline status of CVD and the latter factor can be regarded as an effect modifier in case of 
associations between TABP and CVD mortality. Once the effect of TABP on mortality 
depends on follow-up time, in certain cases there could be an induction period and latent 
period suspected. 
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CVD mortality among CVD-free men at baseline was associated with TABP in different 
manner depending on the measurement scale, but there were relatively few statistically 
significant findings. The Jenkins scale (JAS) showed inverse and non-significant association 
with TABP (hazard rate ratio (HRR) down to 0.90 and below), while the Bortner scale (BRS) 
showed almost no effect and was statistically non-significant. Meanwhile, the Framingham 
scale (FTAS) showed more inverse association in later decades (down to HRR=0.70 and 
below) but very high in early stages of follow-up (HRR=2.00 and above). The Finnish scale 
(FINT) was showing quite clear inverse associations, oscillating at levels of HRR=0.50. the 
specially constructed Multiscale Assessment (MSA) showed less expressed inverse 
associations between TABP and CVD mortality among CVD-free individuals. The strongest 
associations were observed with Cynical Distrust Scale (CDS), where the risk for upper 
quartile was at HRR=2.00 and above with the trend declining with longer follow-up time. It 
can be concluded, that among CVD-free middle-aged men the risk for CVD death seems to be 
increased only with high levels of cynicism, but not with high levels of the Type A (and if so, the 
trend is more towards inverse association). 
Similarly, for CVD mortality among subjects with prior CVD the associations of TABP 
were mainly either absent or with slight inverse trends and there were less variation of 
associations across the scales. The Jenkins scale showed mainly inverse associations down 
to HRR=0.80 and below, mainly non-significant. Similar pattern was observed with the 
Bortner scale, though in early stages up to 11 years it showed the risk effect of TABP. The 
Framingham scale was opposite to the Bortner scale in that it showed more inverse 
associations in early stages than in later ones, though the associations still were below 
HRR=1.00 (inverse). Meanwhile, the Finnish scale was mostly similar to the Jenkins scale 
and majority of associations were at levels of HRR=0.60. Since the Multiscale Assessment 
was a derivative of the original four Type A scales, the associations of TABP as assessed by 
MSA and CVD mortality were intermediate of all the original TABP scales, showing inverse 
associations at levels of HRR=0.90. The strongest associations were observed with the 
cynicism scale at middle and late stages of follow-up, though the risk for upper quartile did 
not exceed HRR=1.20 (lower than found for CVD-free individuals). It can be concluded, that 
the TABP seems to be associated with CVD mortality among middle-aged and aging men who had 
CVD history at baseline rather in inverse manner, while the cynicism seems to be a risk factor, at 
least in latest stages of follow-up. 
CVD mortality in total study sample. The effect of TABP on cardiovascular mortality 
was also calculated for the whole sample, where in survival model the prior CVD was 
included as a covariate. Here almost all scales showed only inverse associations of different 
strength. The lowest risk of CVD death was among extreme the Type As defined by the 
Finnish scale (about HRR=0.60). Slightly higher risks were for the Type As defined by the 
Jenkins scale (about HRR=0.70), and more closely to no-difference levels – for the Bortner 
and Framingham scales as well as for the Multiscale Assessment (about HRR=0.90). In 
contrast to the Type A scales, the Cynical Distrust Scale was consistently associated with 
the risk of CVD death showing the effect at levels of HRR=1.40. Therefore, it can be concluded, 
that it is the cynicism rather than the Type A which is associated with an increased risk of 
cardiovascular death in middle-aged and aging men. 
The associations of non-CVD mortality were calculated for the whole sample regardless 
of CVD status at baseline. Of note, early follow-up (6 years) consistently showed the TABP 
as a risk factor, but in later years this unanimity was fading and for some scales came down 
to levels below HRR=1.00. The Jenkins and Bortner scales were very similar with the risk 
around HRR=1.50 at 6 years and about HRR=1.00 in later years. In contrast, the 
Framingham, Finnish, and MSA scales had clear trends of high risk of mortality in early 
stages of follow-up (levels of HRR=2.00 and above) and approaching to no-difference levels 
in later years. The cynicism scale showed positive associations with non-CVD mortality 
throughout the whole follow-up, ranging from HRR=1.15 to HRR=1.43. This was the most 
consistent effect across the analyzed scales. In certain time window though, the highest 
47 
 
 
observed risk was for the Finnish scale which from the years 6 to 16 showed non-CVD 
death risk from HRR=2.79 to HRR=1.44, but at the years 21–26 it was almost equal to the 
reference level of HRR=1.00. It can be concluded, that the TABP seems to be associated with 
increased non-CVD mortality during the first 10–15 years of follow-up and not so consistently later 
while the cynicism seems to be a consistent risk factor regardless of the follow-up. 
To make the long things short, the results of the study show that the cynicism is 
considerably more associated with the mortality than the Type A behavior pattern. 
Additionally, the associations of TABP and mortality are strongly depending on 
measurement scale and follow-up time, while the robust findings are relatively rare. These 
findings are of high scientific validity, since the analyses are based on longitudinal study 
with relatively long follow-up including a representative sample of individuals, higher risk 
sample, and using a strong outcome measure – mortality. 
6.2 METHODOLOGICAL ASPECTS 
6.2.1 Study population 
The Kuopio Ischemic Heart Disease Risk Factor study (KIHD) is well known for its 
representative sample. The study reached almost 83% of representative population that was 
invited to participate in the study with no significant differences between participants and 
non-participants concerning sociodemographic indicators [Lakka & Salonen 1992]. 
Altogether, the study population comprised of 2,682 men. This is relatively moderate 
sample size compared to 12,866 subjects in the MRFIT study [Hollis et al. 1990], 3,154 in the 
Western Collaborative Group Study (WCGS) [Rosenman et al. 1975] or the GAZEL study in 
France [Lemogne et al. 2010] with 20,625 individuals. Still, it is a large sample compared to 
the Framingham Heart Study (FHS) [Haynes et al. 1980] with 1,674 subjects or the KRIS 
study [Goštautas & Perminas 2004] with 2,455. In context of Finland, the study is rather 
large-scale, since the Finnish studies on TABP conducted before had usually smaller 
samples, such as the Cardiovascular Risk in Young Finns Study with 1,014 subjects 
[Keltikangas-Järvinen et al. 2007] or Julkunen’s et al. study on 92 individuals [1993], though 
the Finnish Twin Cohort Study [Koskenvuo et al. 1983] had larger sample. 
The original epidemiological evidence [Rosenman et al. 1975] came from the study on 
non-manual male workers who may encounter more situations likely to elicit the TABP and 
have more control on their working environment. Later studies investigated more different 
samples and the results came sufficiently different. Therefore, the KIHD sample provides 
very useful information for associations in healthy population. It was suggested that the 
TABP is only predictive in a healthy low risk sample and not in a high risk sample 
[Johnston 1993], which is partly supported by our findings that for subjects without prior 
CVD the prognostic validity of TABP is more expressed compared to men with prior CVD. 
Carroll [1995] stated that the prospective studies that follow-up the healthy individuals 
provide the best evidence about TABP and health outcomes. 
Our study was population-based which means that it is a representative of general adult 
and aging male population in Kuopio area. The systematic review of the studies on TABP 
and hostility [Hemingway & Marmot 1999] found that in healthy populations, the 
prospective cohort studies show only possible etiological role of Type A and hostility (6 of 
14 studies), while in patients with coronary heart disease (CHD) such studies do not show a 
prognostic role (0 of 5 studies; 1 showing even inverse association). The majority of our 
calculations were done on representative population that can be considered relatively 
healthy. Additionally, estimates of TABP and CVD mortality were separately calculated for 
population with prior CVD that can partly be considered as subjects at higher (if not high) 
risk of CVD. Other studies also included healthy individuals (e.g. [French-Belgian 
Cooperative Group 1982] [Lemogne et al. 2010] [Ragland & Brand 1988b]) or persons 
without cardiovascular problems (e.g. [Eaker et al. 1989] [Goštautas & Perminas 2004] [Shen 
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et al. 2008]), but usually and more frequently the studies were on subjects with CVD 
problems (e.g. [Dembroski et al. 1989] [Hori et al. 2003] [Julkunen et al. 1993]). Having the 
representative sample of population enables less potential for bias, since many positive 
findings came from the studies with a very high prevalence of TABP (60–75% based on the 
Structured Interview) [Manuck et al. 1986]. This suggests the possibility that the systematic 
selection and referral biases may have influenced the subject recruitment in some studies 
and subsequently had effect on associations found there. In contrast, Matthews & Haynes 
[1988] concluded that the TABP was a risk factor for CHD in population-based studies, but 
that studies of high risk populations “fail to consistently support the hypothesis that Type 
A behavior is a risk factor for recurrent events or for mortality”. 
The KIHD study is one of very rare TABP cohort studies done on a representative 
sample – since the studies including general population from the communities were only 
few ([Kawachi et al. 1998] [Zhang et al. 2004] [Appels 1984] [Goštautas & Perminas 2004]). 
From perspective of sample’s age structure our study is quite similar to previous studies on 
the issue. Similarly, our study followed another trend – it included only men, because 
somehow, the previous TABP research included more men than women, some cohorts 
being totally masculine (such as Western Electric Study, WCGS, KRIS, MRFIT). This enables 
to draw conclusions specific for a gender, especially valuable in case were the gender has 
an effect modification, because the association between TABP and health outcomes could 
be gender-specific. For instance, the follow-up of a large 86,361 subjects sample in Japan 
revealed that men with lowest Type A scores have 32% greater risk of CHD incidence and 
35% higher risk of myocardial infarction (MI), while in women the differences were non-
significant [Ikeda et al. 2008]. However, the latter study used original 4-item self-reported 
scale that cannot be compared to classic versions of TABP assessment. 
Additionally to the sample issue, the WCGS study that was the booster of TABP and 
health findings included not a random representative sample of middle-aged men – about 
80% were employed in white collar occupations (these were mainly white male managers 
in California). Therefore, the study was socioeconomically and regionally biased and the 
applicability as well as extrapolation of its conclusions has some limitations. Similarly but 
maybe a little less expressed, the Framingham Heart Study had also limited 
representativeness – it was a suburb of Boston, including women but no African 
Americans. Therefore, our study sample has quantitative and qualitative features that allow 
to revise the issue of TABP and mortality. 
6.2.2 Study design 
The KIHD study was a prospective cohort study. This is a well-characterized cohort study 
of men with a long follow-up time (26 years to date) and random sampling. The cohort 
study has been a common design of research on TABP and health outcomes. The main 
earlier cohort studies were conducted in the United States (e.g. the WCGS [Rosenman et al. 
1975], the MRFIT [Shekelle et al. 1985], the FHS [Haynes et al. 1980]), but there were also 
some studies of this design conducted in Europe (the KRIS in Lithuania [Goštautas & 
Perminas 2004] and the Netherlands [Appels 1984], the GAZEL study in France [Nabi et al. 
2005], the French-Belgian Pooling Project in Belgium and France [French-Belgian 
Collaborative Group 1982]), including Nordic countries (the Cardiovascular Risk in Young 
Finns Study [Keltikangas-Järvinen et al. 2007], the Finnish Twin Cohort Study [Koskenvuo 
et al. 1983], the Oslo Study in Norway [Søgaard et al. 2008]), and some cohort studies have 
been conducted in East Asia, especially in Japan (Japan Public Health Center-based 
Prospective Study [Ikeda et al. 2008] [Kato et al. 2009]). The duration of follow-up in those 
cohort studies ranged from a few years to 27 years, with majority of cohort studies 
reporting the results from shorter than 10 years follow-up. Therefore, our study has very 
long follow-up and the framework of analyses of our study provides very good material for 
evaluation of how much the follow-up time has influence on the association between 
exposure and outcome and how robust these associations are. It can be suggested that the 
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Kuopio Ischemic Heart Disease study represents one of the strongest TABP research with 
respect to potential for causal inference, and is among the longest in terms of follow-up (up 
to 26 years). Therefore, the findings of this study are likely to have less bias as compared to 
many of the other previous studies. 
6.2.3 Measurement of TABP 
When trying to measure a certain psychological phenomenon within individuals, the 
interview and the questionnaire are the most common techniques. However, the larger the 
study sample is the less likelihood that the study will conduct interviews – there are 
restrictions in logistics, mainly related to time and human resources. Therefore, the majority 
of Type A studies mainly used questionnaires instead of interviews for identification of 
TABP traits. Unfortunately, the pioneers of Type A behavior – Rosenman & Friedman 
[1959] – pointed out that the interview is more fitting for identification of Type A than the 
questionnaire, because in the questionnaire there are many ways to conceal some personal 
features. This earliest assessment tool of TABP was the Structured Interview (SI). Due to 
relevance of non-verbal information obtained during the SI, the questionnaires usually are 
considered inferior to the interview since they are not able to provide non-verbal 
information about an individual, which in turn is relatively important aspect of the Type A 
personality. However, common practice of large-scale cohort studies has been to use 
mainly questionnaires. 
Not surprisingly, only some large-scale longitudinal studies used the Structured 
Interview: the WCGS cohort [Rosenman et al. 1975], the MRFIT cohort [Shekelle et al. 1985] 
and some other studies, mainly small scale cohorts [Powell et al. 1993] [Siegel et al. 1989] 
and cross-sectional studies [Scherwitz et al. 1983]. The rest of Type A research was based on 
questionnaires solely. Among them most commonly used were Minnesota Multiphasic 
Personality Inventory (MMPI; e.g. [McCranie et al. 1986] [Shen et al. 2008]), Bortner Rating 
Scale (e.g. [Gallacher et al. 2003] [Koskenvuo et al. 1983]), Jenkins Activity Survey (e.g. 
[Goštautas & Perminas 2004] [Julkunen et al. 1993]), more rarely – Framingham Type A Scale 
(e.g. [Dishman et al. 1991] [Haynes et al. 1980]), Finnish Type A scale ([Julkunen et al. 1993]) 
or other scales. The KIHD study as a large-scale study has also chosen to use the 
questionnaires – Jenkins Activity Survey, Framingham Type A scale, Bortner Rating Scale, 
and Finnish Type A scale. The Bortner, Jenkins, and Framingham scales were associated 
with the SI or CVD risk factors [USDHHS 1985] which justifies the use of those 
questionnaires in epidemiological research. 
The measurements of TABP whichever scale to be chosen have limited validity during 
the follow-up study. This manifests in a potential trend of changing TABP scores during the 
person’s life. In our study we found that there exists a trend of slight decrease of TABP 
scores in elder subgroups of participants: from 42 to 60 years of age, mean FINT score 
decreased from 22.4 to 22.0, JAS score – 157.5 to 156.3, BRS – 15.0 to 14.2, and FTAS from 
13.1 to 12.5. However, we had no opportunity to evaluate whether there were decreasing 
trends during the follow-up within individuals. Moreover, even though there was a trend 
of decreasing scores with aging, but there were exceptions observed – an increase in mean 
TABP score between 42 and 48 years according to JAS (from 157.5 to 162.7) and FINT (from 
22.4 to 22.9) scales, but after 50 the scores started to decrease anyway, though mean JAS 
score at age 60 was only slightly lower than that at age 42. The change of risk factor 
expression (extent of exposure) can have the influence on the presence of outcome – 
mortality. Given these age-group differences and the fact that the participants of our study 
were middle-aged and elderly, we can assume that their risk profile based on TABP score 
had no significant changes during the follow-up and had no essential input to the timing of 
the death. In contrast to the Type A scales, the Cynical Distrust Scale in our study revealed 
clear increasing trend of scores with aging (from 12.2 at age 42 to 13.3 at age 60). This can be 
partly explained by assuming that with older age there start to develop the 
neurodegenerative disorders which often manifest in increased irritability and hostile 
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behavior. However, given that our sample of the study was 42 to 60 years old at baseline, it 
is a question whether such difference could be detected already across these age groups. 
If we suppose that there were no essential changes in TABP within individuals 
throughout the study, another concern is relevant – whether the self-reported 
questionnaires that were used in this study really reflect the personality features. Even 
though it is pretty common practice to use self-reported questionnaires in longitudinal 
studies with relatively big sample size, there is a question of how sincere the answers are 
and whether the subjects do not try (even subconsciously) to ‘look better’ or at least to 
correspond to social desirability, such as being more family-oriented and less overtly 
showing negative attitudes and emotions. Of course, we as researchers usually have no 
chance to avoid this potential for bias, but it should be kept in mind anyway, regardless of 
our opportunity to escape it. 
We assume that the self-reported questionnaires in our study are valid and reflect the 
true state of exposure in participants of the study. However, there were four original TABP 
scales used to establish the exposure extent within individuals and there is no agreement in 
scientific community which of them is better for use. Additionally, the use can be different 
in a way statistical analyses are done (means or ranked categories). Since the scales are 
usually constructed by psychologists, the prime interest in the construction of the scales is 
to reflect the personality features and traits. Unfortunately, the Type A is not just a 
personality characteristic, but rather an action-emotion complex, which manifests under 
certain conditions, and it is still unclear whether high scores in Type A scales reflect more 
personality itself or person’s social environment. Moreover, if we talk about construct 
validity in psychological terms, this does not necessarily apply to the epidemiological 
needs, namely, whether the definition of the TABP as is based on a certain scale is really 
applicable in research on the TABP and health-related outcomes. One of the reasons why 
the cynicism or hostility has been called a possible culprit for associations between TABP 
and health outcomes was that the conventional TABP scales do not pay sufficient attention 
to personality attributes that have negative impact on health and subsequently lead to 
premature death. After all, possible association of TABP and cynicism in the samples of 
studies that have shown the positive association between TABP and health outcomes could 
be responsible for that findings. Meanwhile in our study the cynicism was poorly 
associated with TABP and not surprisingly the findings were more different between TABP 
scales and Cynical Distrust Scale (correlation from -0.05 to 0.15) than among TABP scales 
themselves (correlation from 0.32 to 0.50). 
The idea that the issue of measurement tools is of high relevance is supported by our 
findings which show that TABP scales correlate only to moderate levels. We found that the 
correlation coefficient between four TABP scales ranges from 0.32 to 0.50 and the kappa 
statistic was even lower – ranging from 0.14 to 0.22. Given that our main calculations are 
based on exposure that is categorized rather than kept continuous like in original scales, the 
latter estimates of correlation (kappa statistic) are more reflecting the discrepancies in TABP 
definition that results during the categorization process of the scales. This was the main 
reason why the new Multiscale Assessment score was constructed for this study though 
with reservation that the findings are barely replicable or even not describing the TABP in 
essence, since it did not undergo the proper validation process. 
The psychological and psychometric issues of the scales were not of primary importance 
in this study, because the study was epidemiological (psychosocial epidemiology) and was 
targeted at health-related outcomes rather than the psychological construct itself. 
6.2.4 Bias and confounding 
Selection bias. The KIHD study required participants to fill in quite long questionnaires 
and to participate in examinations at the study site. This could lead to self-selection, where 
those with poorer health refused to participate, leaving the study sample with healthier 
part of population. In addition to that is a fact, that the men with serious disease were not 
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invited to participate in the study [Lynch et al. 1996]. This all could influence the occurrence 
of outcome in study sample. Nevertheless, probably there could be no significant potential 
for bias about the study exposure – Type A, because no sociodemographic differences were 
found between participants and non-participants [Lakka & Salonen 1992]. Of note, 
institutionalized men were not enrolled to the study, but presumably they comprise very 
small portion of the general population. 
Gender-specific selection bias was avoided in our study since the sample comprised only 
of men. Even though the extrapolation of findings due to that fact is also gender-specific 
only, but the sample of one gender individuals unchains the analyses of any possible effects 
of gender – either as a covariate, or as an effect modifier. 
Information bias. All scales of interest were categorized despite the fact that the 
distributions of those scales were non-Gaussian. However, the categorization of ordered 
variables in defining the exposure has some limitations. Such transformations of variables 
can be harmful to power, precision, and confounder control [Rothman et al. 2008, p. 303]. 
Additionally, the percentile limits make it difficult to compare the associations and effects 
across different studies, because the limits of ordinal categories are different for every 
single study. This means that the results on quartiles are sample-specific, which could be 
treated similarly like the IQ comparisons across countries and societies. Moreover, 
categorization of continuous variable to the ordinal one can lead from non-differential to 
differential error which in turn increases the likelihood of bias toward the null difference 
[Rothman et al. 2008, p. 143]. The Type A like the IQ is a relative term, since it has no 
absolute cutoff but relative instead, which heavily depends upon the distribution of feature 
in general population. Therefore, the comparison of subgroups according to differentiation 
based on real distribution has serious limitations due to possible heterogeneity within 
certain subgroups across different studies. 
Through categorization of original scales the potential for recoding bias emerged. By 
recoding continuous assessment variables into quartiles, some scales, especially with a 
lower number of maximum points (less than 25), formed the quartiles of remarkably 
different size, being over- or underrepresented comparing with other quartiles. Though, 
Matthews & Haynes [1986] claimed, that when Type A is assessed by a measure which 
yields categorical data (the SI), there is no linear relationship. On the contrary, when the 
TABP is assessed by continuous measure and then is divided into categories, there is an 
evidence (though, not consistent) for a linear relationship. This conclusion is based only on 
those studies reporting a significant association between TABP and CHD. The large amount 
of predictor variables was chosen due to the lack of sufficient data showing conclusively 
what aspects of the Type A are coronary-prone (or disease-prone) and what aspects are not. 
It is quite likely that TABP is not a stable characteristic and a classification carried out in 
the middle age may not apply to the elderly [Johnston 1993]. Our sample suggests that this 
could be true, because in majority of TABP assessment scales there was observed a trend of 
lower average scores with older ages. Similarly, as noted from the WCGS study and the SI 
measurements [Carmelli et al. 1991], more than one third of individuals can shift from the 
Type B to Type A or vice versa within a period of a decade or longer. 
Our study revealed that the correlation between the TABP scales was moderate, ranging 
from 0.32 to 0.50. The comparisons of Bortner, Framingham, and Jenkins scales indicate 
generally modest levels of agreement, though previously they showed higher correlation 
with the SI than among themselves [Carroll 1995]. Given the different structure of 
questionnaires it is not surprising that the results using different sets of questions provide 
only moderate agreement on association of TABP and mortality. Additionally, the speech 
characteristics that provide substantial information on TABP are observable only during the 
SI, which is hardly possible to obtain in large-scale studies using self-reported 
questionnaires. Matthews [1982] attempted to characterize how 3 different measures 
emphasize the TABP and concluded, that the SI points to “general reactivity to 
psychological events that are frustrating, difficult, and moderately competitive”, the 
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Jenkins scale – “vigorous achievement strivers, who can be aggressive and competitive”, 
and the Framingham scale – “dissatisfied and uncomfortable with the competitive 
orientation and job pressure that their lives entail”. Altogether he concluded that while the 
SI, Jenkins, Framingham, and Bortner scales purport to measure the same behavioral 
attributes, correlations among the measures are low, and discrepant Type A-Type B 
classifications occur frequently when two or more of these instruments are administered to 
the same individuals. It was later supported by findings that the global TABP correlates 
with such paralinguistic features like loudness, explosiveness and rapidity of speech, and 
only secondarily by hostile attitude or behavior [Dembroski et al. 1989] [Dembroski & 
MacDougall 1983], which could partly explain why self-reported questionnaires do not 
detect the association between TABP and mortality. 
Meanwhile the newly constructed MSA score showed higher correlation with original 
Type A scales than the intercorrelations between them. This can be explained by fact that 
the new scale is a derivative of the original ones and therefore from the statistical point of 
view it has a priori tendency to increased correlation. 
Control for confounding. Confounding control is usually performed through 
adjustment for covariates. Such covariates can be divided into 2 subgroups – biological 
(including behavioral) and psychosocial (including socioeconomic) covariates. 
Among biologic covariates the most important is the age or age group (included in 
majority of the previous studies). Other biological covariates are conventional risk factors 
for cardiovascular or total mortality – smoking (e.g. [Almada 1991] [Eaker et al. 2004] 
[Haukkala 2010]), blood pressure (e.g. [Dembroski et al. 1989] [Houston et al. 1997] 
[Shekelle et al. 1991]), alcohol consumption (e.g. [Almada 1991] [Haukkala 2010] [Shekelle 
et al. 1991]), and serum cholesterol (e.g. [Dembroski et al. 1989] [Eaker et al. 2004] [Shekelle 
et al. 1991]). Another biological covariates have been adjusted relatively rarely, e.g. cancer 
status ([Carmelli & Swan 1996]), diabetes ([Jenkinson et al. 1993]), gender ([Lemogne et al. 
2010]), body mass index ([Haukkala 2010]) etc. The other group – psychosocial covariates – 
has been adjusted less frequently. These were other psychological or personal traits such as 
hostility (e.g. [Carmelli & Swan 1996] [Houston et al. 1997]) or depressiveness ([Haukkala 
2010]), as well as socioeconomic indicators such as education level (e.g. [Eaker et al. 2004] 
[Haukkala 2010] [Nabi et al. 2008]) or marital status. 
Our study included 10 covariates – 7 biological (age group, serum cholesterol, body mass 
index, physical activity, smoking, blood pressure, and alcohol consumption) and 3 
socioeconomic (occupation, education, and income). Additionally, for CVD mortality 
analyses, the prior history of CVD was added to the set of covariates. In light of previous 
studies on TABP, our study followed the mainstream in its adjustment scenario and our 
control for confounding was satisfactory at least or optimal at best. 
However, even after adjustment and control of confounding, it can be residual 
confounding left – either because of lack of other significant confounders that were not 
considered in the analyses, or due to improper statistical shape of considered confounders 
(e.g., having categories instead of continuous variables [Rothman et al. 2008, Figure 12-6 p. 
198–199]). 
Another one issue is related with the assumption that the putative confounders as risk 
factors are likely to change during the follow-up and in this way change the likelihood of 
the outcome – mortality. Therefore, the potential for confounding emerging from risk 
factors that manifest later than the baseline has not been estimated and neither was 
controlled for in our study. Covariates could also have the potential for information bias 
like the exposure estimates. Moreover, there is always a possibility for unmeasured 
confounding that was not adjusted for – either because it was not included to the set of 
covariates, or because it was not measured in the study sample. Unknown covariates are 
not possible to adjust for regardless of the statistical models chosen. 
Among the shortcomings of control for confounding it can be mentioned, that in early 
years of the cohort, the data are too thin given the range of potential confounders. 
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Therefore, the estimates of effect have large confidence intervals when adjusted for 
confounding in early years of follow-up. 
6.2.5 TABP and mortality depending on scale and follow-up 
There were not as many other studies like the Kuopio Ischemic Heart Disease study where 
the estimates of TABP were conducted using several original questionnaires on the same 
individuals. We analyzed the Bortner, Jenkins, Finnish, and Framingham scales. Other 
known studies were reported by Dishman et al. [1991] and Gallacher et al. [2003]. As an 
outcome, the former study estimated the perceived exertion during the graded exercise, 
and the latter evaluated the CHD incidence – thus, none was evaluating health outcomes in 
a broader scope. The huge majority of studies on TABP issue have been using only one 
method for evaluation of the Type A whichever outcome of interest to analyze. Therefore, 
the following discussion of study results will be based on measurement instruments and 
findings on TABP and health outcomes associations. Where the comparison of subgroups 
in previous studies has not been calculated as hazard ratios or risk ratios or odds ratios, the 
differences were additionally calculated by dividing certain indicators of the subgroups as 
proxy estimates of effect. The hazard rate ratios of present study are discussed as the 4th 
quartile’s (the most extreme Type A) estimates compared to the 1st quartile (reference 
group). 
1. Jenkins Activity Survey. The Jenkins Activity Survey as a scale was designed for 
adult working males [Riska 2006] therefore it can be suggested that the questionnaire is 
fitting our study with a sample of middle-aged and aging men. By using the Jenkins scale 
we found that at 6 years of follow-up the CVD mortality was different depending on CVD 
history at baseline – for the Type A subjects without CVD history the risk was HRR=1.38 
while for the ones with CVD history it was HRR=0.99. In later follow-up those risks were 
becoming similar, in some cases being higher for CVD-free individuals, in others – for men 
with prior CVD. In any case, the risk was below the reference level (about HRR=0.80). The 
risk of cardiovascular death in total KIHD sample was about HRR=0.70 to HRR=0.80. In 
short, the TABP as measured by JAS showed rather inverse association with CVD 
mortality. Meanwhile, the association of non-CVD mortality and TABP had the trends of 
no-difference, except at 6 years of follow-up (HRR=1.47). However, regardless of long 
follow-up and relatively large sample, all those trends did not reach statistical significance. 
In short, the JAS scale in our study seems to be not associated with mortality in middle-
aged men, and still shows a potential for inverse association. 
Most similar study on mortality and JAS scores was the Multiple Risk Factor 
Intervention Trial Group study [Hollis et al. 1990] with the sample of more than 12,000 men 
aged 35 to 57 years. However, these were men in top 10 to 15% of CHD risk based on 
diastolic blood pressure, serum total cholesterol, and number of cigarettes smoked per day. 
So, this was a high risk population, at least for CVD mortality. Analyzed follow-up time 
was 6 years. The reference group was defined as the JAS score below 5, and index group – 
all others. The researchers found that high JAS score was associated with decreased CHD 
mortality and total mortality (P<0.01), like in our study with population-based sample and 
CVD mortality. By the end of our follow-up at 26 years, the highest JAS score was 
associated both with decreased CVD and non-CVD mortality (P>0.05), which partly 
supports the findings of inverse association from the MRFIT cohort. The same study also 
reported the results earlier, but from mean follow-up of 7.1 years [Shekelle et al. 1985] and 
found that the TABP was not associated with increased incidence of coronary events 
(P>0.05). Thus, the results of MRFIT study show that there exists either no association of 
TABP to CVD events or it is even inversely associated in high risk samples. 
The Caerphilly Study [Gallacher et al. 2003] in the United Kingdom evaluated the CHD 
incidence depending on TABP after 5 and 9 years of follow-up. The sample was 2,884 men 
aged 50 to 64 years, quite similar to ours but slightly older. They did not use survival 
analyses though this was a cohort study and calculations were adjusted for psychosocial 
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and biological covariates. They found that among the men free of CHD at baseline, the 
CHD incidence was associated with higher JAS score at 5 years and lower – at 9 years 
(P>0.05). Our study results are similar at 6 years of follow-up for CVD mortality among 
CVD-free individuals (P>0.05), which supports the Caerphilly Study findings with more 
expressed differences from reference. When evaluating all study subjects, the Caerphilly 
Study had also similar findings, but closer to no-difference than among CHD-free men, in 
contrast to our study were in all subjects the risk at 6 years showed possible protective 
effect of TABP. Despite some differences in findings, the Caerphilly Study supports the 
absence of association, because the differences were non-significant and the estimates were 
close to no-difference, though our study had more dispersion in comparable findings. 
The analysis of Lithuanian part of KRIS study [Goštautas & Perminas 2004] was 
performed only having the myocardial infarction (fatal or non-fatal) as an outcome. The 
study started with an invitation of 3,553 MI-free men, but ended up in the analysis of only 
1,806 (50.8%) men meeting the criteria – this shows rather moderate representativeness of 
the sample compared with our sample of 82.9% of eligible population. They followed up 
men for 24 years and made calculations for 8 years intervals without adjustment for 
confounding. The authors found that in first 8 years the MI incidence was higher in Type 
As than other subjects (P=0.90), more in later 8 years (P=0.20), and most in the last 8 years 
(P=0.08). However, the authors did not clearly define whether the incidence in the 2nd and 
the 3rd periods were cumulative or not, though the trends looked clearly cumulative, i.e. 
including 16 and 24 years of follow-up, respectively. Our comparable results were rather 
opposite, showing inverse associations of the Type A and CVD mortality (P>0.05). Such 
comparison of the results shows clearly different pattern of associations – the KRIS study 
shows the TABP to be a risk factor for MI incidence, while our study shows TABP as a 
protective factor against CVD mortality. The limitations of this comparison include 
different outcomes and slightly different comparison years as well as some reservations 
about populations under study. 
Similarly like the studies mentioned above, the null associations were also found among 
the other middle-aged men samples such as the Honolulu Heart Project [Reed & Cohen 
1982], Dutch part of the KRIS study [Appels 1984], and the Physical Fitness Study in 
Belgium [Kittel 1985]. In this perspective, the findings from the WCGS study look like the 
outliers among the other studies that have used the JAS questionnaire. The WCGS included 
3,154 healthy employed men, mainly white Americans. After 4 years of follow-up they 
found twice a risk CHD incidence for Type As as measured by the SI [Jenkins et al. 1974]. 
Later on, based on 8.5 years of the follow-up the main booster of TABP and CHD was 
publicly reported [Rosenman et al. 1975]: based on the SI scoring, the Type A compared to 
B was associated with increased risk of MI, but the associations based on JAS were quite 
close to no-difference. Meanwhile in our study at comparable follow-up points the CVD 
was lower among Type A individuals (P>0.05) which supports the absence of association. 
Therefore, it can be concluded that there exists sufficient evidence that the TABP as measured by 
the Jenkins Activity Survey seems to be not associated with cardiovascular and non-cardiovascular 
mortality. 
2. Bortner Rating Scale. In the Kuopio Ischemic Heart Disease study, the Bortner Rating 
Scale’s associations with TABP showed more different trends throughout the follow-up 
than the Jenkins scale but there were no statistically significant findings either. Here, the 
first decade of follow-up had a trend of increased mortality for Type As compared to Type 
Bs. In later years it could have been considered as a risk factor only occasionally. 
There were also other studies estimating the TABP using the Bortner scale. The majority 
of so-called positive findings came from the Belgian-French Collaborative Heart Disease 
Study [Belgian-French Pooling Project 1984]. This study was conducted on healthy men 
with 5 years of follow-up. There has been found that the TABP is associated with incident 
CHD [French-Belgian Collaborative Group 1982]. Similarly positive associations were also 
found by Kornitzer & Lellouch [1984] on 40–59 years old men. Our comparable findings 
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after 6 years of follow-up showed the risk very close to no-difference both in total sample 
and CVD-free subsample. In our study, in later years the TABP measured by BRS scale 
seemed to be more associated with the decreased rather than increased risk of fatal events. 
Similarly like ours, many later studies were not able to detect the risk effect of the Type 
A as measured by BRS scale. Such null findings appeared relatively early (such as [Jouve et 
al. 1980] on 40–59 years old men and [Koskenvuo et al. 1983] on 35–64 old Finnish men). 
Among the studies with the null findings were also two British studies that failed to find an 
association even despite large samples [Johnston et al. 1987] [Mann & Brennan 1987]. 
Moreover, the British Regional Heart Study [Johnston et al. 1987] including 6,177 men 
found that the TABP as measured by BRS is associated with lower CHD incidence, though 
the association was not statistically significant and was attenuated by the effect of other risk 
factors. This supports our findings that show almost no risk effect of TABP as measured 
using the Bortner scale or even slightly inverse associations. 
Another British study, the Caerphilly Study [Gallacher et al. 2003] evaluated the CHD 
incidence depending on TABP after 5 and 9 years of follow-up in 2,884 men aged 50 to 64 
years. They found that among the men free of CHD at baseline, the CHD incidence was 
associated with lower BRS score at 5 years and at 9 years. Our study clearly supports these 
findings. The Caerphilly study supports the absence of association, because the differences 
are non-significant and estimates are quite close to no-difference. 
There is one ongoing cohort study that uses the Bortner scale as measure of TABP – the 
GAZEL study in France. Earlier analysis was based on mean 12.7 years of follow-up [Nabi 
et al. 2008] and later – on 14.8 years of follow-up [Lemogne et al. 2010]. The study 
investigates 20,625 employees or recent retirees of national gas and electricity companies 
(15,011 men and 5,614 women) aged 40–50 years (men) and 35–50 years (women). This 
study is unique among others that for an estimate of association they use the relative index 
of inequality (RII), however, they did not mention how they defined the TABP based on 
BRS scale (no information on cutoffs or categorization). The earlier report [Nabi et al. 2008] 
found that the Type A was associated with decreased risk of total mortality and CVD 
mortality (P>0.05). Meanwhile in our study the CVD mortality after 11 years was slightly 
higher than the reference (P>0.05); an earlier GAZEL study reported more potential for 
inverse association of TABP and mortality than our study, though in majority of cases the 
findings were still non-significant. Additionally, that study found that the risk for cancer 
death is even more decreased than the total mortality, while the death due to external 
causes was slightly more common but still below the reference (P>0.05). The later GAZEL 
report [Lemogne et al. 2010] was based on 2 years longer follow-up and added not much to 
the picture on TABP and mortality association – they found that TABP is associated with 
decreased risk of total mortality (P>0.05, adjusted for age, gender, biological, and 
psychosocial covariates). 
In total it can be concluded that the TABP as measured by the Bortner scale is either not 
associated with subsequent mortality (sufficient evidence) or associated with lower mortality 
(insufficient evidence). 
3. Framingham Type A Scale. In our study, the CVD mortality depending on TABP 
expression based on the Framingham Type A scale showed some associations, but majority 
of them were showing rather inverse relationships, especially starting from the middle 
follow-up. Here, the most remarkable associations (but not statistically significant) were 
observed up to 11 years of follow-up when the 4th quartile consistently had a higher risks of 
CVD death. In latest years of follow-up the ‘protective’ trend even reached statistical 
significance for CVD-free individuals. Meanwhile, non-CVD mortality was also decreasing 
from HRR=1.62 at 6 years to HRR=0.86 at 26 years (both non-significant). Associations were 
found also in men with CVD history starting from the second decade of follow-up. 
Unlike the Bortner and Jenkins scales, the studies using the Framingham scale for the 
assessment of TABP are much more rare. However, even the studies using this scale 
propose sufficient material for doubt about negative impacts of the Type A on health. The 
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study that constructed this measurement technique (supposed for other than male 
managers [Riska 2006]) was the Framingham Heart Study, including 1,674 men and women 
aged 45–64 years and coronary-free. After 8 years of follow-up [Haynes et al. 1980] the 
results showed higher than the double risk effect. In our study after 6 years of follow-up it 
was found that the Type A men who were CVD-free at baseline had also higher than the 
double risk of premature CVD death (P>0.05). However, in later years these estimates in 
our study tended to decrease dramatically, going straight down, crossing no-reference at 16 
years and getting as down as HRR=0.55 (P=0.027) by the end of follow-up. This could be 
partly explained by the strongest survivor effect, though this somehow does not apply to 
men with CVD history at baseline and was not observed so clearly using the Jenkins and 
Bortner scales. Absence of risk effect was supported by later analysis of the Framingham 
study [Eaker et al. 1989] based on 20 years of follow-up which concluded that the TABP is 
not related with an increased risk of fatal coronary events, which can be supported by our 
findings as well. 
The only study except the FHS to be found reporting results based on the Framingham 
scale was the Caerphilly Study [Gallacher et al. 2003] in the United Kingdom. It evaluated 
the CHD incidence depending upon the TABP after 5 and 9 years of follow-up in 2,884 men 
aged 50 to 64 years. They found that among CHD-free men at baseline, the CHD incidence 
was associated with very slightly increased Framingham score at 5 years and at 9 years, 
while in our study such estimates were clearly above the reference level (but still P>0.05). 
When evaluating all study subjects, the Caerphilly Study reported few differences that are 
even closer to no-difference than among CHD-free men, quite similar to ours. The 
Caerphilly study supports the absence of association, because the differences were non-
significant and the estimates were quite close to the reference level. 
In a whole it can be concluded that the TABP as measured by the Framingham scale is not 
associated with the cardiovascular or non-cardiovascular mortality among middle-aged men. 
4. Finnish Type A Scale. Other Type A scales had very limited applicability in health-
related studies. In our study, the Finnish Type A scale showed relatively many statistically 
significant associations with subsequent mortality compared to other scales. Concerning the 
CVD mortality, the Type A individuals had trends of significantly lower risk of CVD death 
than Type Bs (from 21 years onwards this was statistically significant at levels of 
HRR=0.60). Such inverse association was more expressed in subjects without CVD history 
at baseline. However, opposite and statistically significant trends were observed regarding 
non-CVD mortality, but the risk for Type As was decreasing from HRR=2.79 (P=0.020) at 6 
years to HRR=1.01 at 26 years of follow-up. In short, TABP as measured by Finnish scale 
seems to have potential for associations depending on the outcome and follow-up time. 
There was only one study found that used the Finnish scale for assessment of TABP and 
health outcomes. It included 92 individuals (76 men and 16 women) aged below 65 years, 
who were survivors of acute phase of the first MI [Julkunen et al. 1993]. This was a short 
follow-up that has observed the subjects for a one year looking to the endpoints of the MI. 
The study was not able to find associations with TABP measured by Finnish and Jenkins 
scales in that short-term period. 
5. Multiscale Assessment. The newly developed Multiscale Assessment score has 
shown similar mortality trends like the Finnish Type A scale – CVD mortality lower or 
equal for Type As compared to Type Bs, while non-CVD mortality – vice versa. Like in 
many other scales, the trend was showing smaller differences between the subgroups of 
TABP in later years of the study than in the first decade. However, unlike the Finnish scale, 
the MSA did not show any statistically significant associations. The only borderline 
significant association was at 6 years concerning non-CVD mortality (HRR=1.71, P=0.053) 
but later on this trend disappeared to HRR=1.07 at 26 years of follow-up. 
MSA has been created solely for the analysis of this study and is not intended to use 
elsewhere, mainly due to practical reasons as well as scientific validity (no analyses on 
construct validity for this scale). It was constructed in order to equalize the differences 
57 
 
 
within subjects emerging due to different ‘labeling’ based on the original Type A scales. 
There is hardly a need for new inventories of TABP measurement, though there are still 
new emerging of this kind, such as the ERCTA (Rodriguez Sutil 1998) or the Type-A 
Personality Scale [Batigün & Sahin 2006]. 
6. Follow-up time. Partly, the associations between the TABP and health can be 
explained by the follow-up time. In our study, starting from years 11 or 16, the risk for the 
upper quartile had a trend to decrease whichever scale used. This can be due to healthy 
survivor (or healthy user, or strongest survivor) effect. On the other hand, once the TABP 
serves as a fatal predictor, perhaps the Type A individuals having other particular disease-
prone traits die at younger ages leaving older generation without these traits or under-
distribution of those. This partly can be supported by Jenkins & Zyzanski [1980] whose 
review led to assumption that the TABP is a stronger risk factor in the younger men than in 
older men. Such association can weaken with longer follow-up because across the different 
age groups it seems that the TABP is getting less expressed with aging and therefore has 
less potential for negative effects on elder individuals. 
Additional explanation can be that the Type A can be fading away throughout the 
lifespan, which is indirectly supported in our study, where the average Type A scores were 
lower in elder groups for most Type A scales. This was supported also in cross-sectional 
study about the Bortner scale distribution across different elder than 40 years age groups of 
men [Koskenvuo et al. 1981], but had increasing trend before 40s [Koskenvuo et al. 1981] 
[Järvikoski & Härkapää 1987]. 
The largest and most convincing study of over 2,000 patients undergoing coronary 
angiography showed that the TABP was associated with increased likelihood of coronary 
artery occlusion in younger patients but not in those in late middle age or above [Williams 
et al. 1988]. The authors suggested that this was due to the survival of those in whom the 
TABP makes less personal risk, since more of those susceptible to this risk factors will have 
experienced an acute myocardial infarction or death. 
Weaker associations in later years can be explained in a way that the random variation of 
mortality throughout longer follow-up starts playing much less role and therefore the 
associations get weaker. 
7. Overview. Altogether, in our study there were found more clear associations between 
mortality and the TABP as assessed by Framingham and Finnish rather than Jenkins and 
Bortner scales. The former two showed more inverse associations (though statistically non-
significant), while the latter two – more null findings. It seemed that the self-reported 
questionnaires had no predictive value for health outcomes, especially hard outcomes such 
as mortality or severe CVD events. Even though the Western Collaborative Group Study 
was the only large-scale study that used the SI for an assessment of TABP and found the 
association with CHD incidence [Rosenman et al. 1975], even this study failed to show 
consistent associations over the long term [Ragland & Brand 1988b]. Regardless of the fact 
that the WCGS was the study boosting the issue of Type A – health outcome association by 
establishing double risk for CHD incidence among healthy middle-aged men in 8.5 years of 
follow-up, no association was found later, based on results of 22 years follow-up analysis 
on CHD mortality. This was tried to be explained by Bennett & Carroll [1990] who claimed 
that there could be positive behavioral change after the onset of CHD which could retard 
further progression of the disease and lead to better health condition, but this could not be 
very likely in later stages of life. 
Additionally, the definition of the outcome can play a role, while the association between 
the TABP and coronary heart disease observed in healthy adults in studies which included 
angina pectoris as an outcome (angina pectoris correlates with TABP both in cross-sectional 
and cohort studies [Myrtek 2001]) may be due to one large, early study that same booster 
study – the WCGS [Rosenman et al. 1975]. No associations were found in studies which 
used a more stringent design (i.e. not including angina as an outcome). 
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The possible association between TABP and cynicism or hostility in the samples of 
studies that have been investigating TABP associations with health but not considering the 
cynicism can partly explain the associations found between TABP and negative health 
outcomes. Similarly, the publication bias could also have played a significant role. 
6.3 CYNICISM AND MORTALITY 
The inconsistent associations between TABP and CHD led investigators to examine 
individual facets of this multicomponent construct on the assumption that some specific 
characteristics may be more relevant to health than others. Such studies identified 
behavioral ratings of hostility as the best predictor of CHD among the various TABP traits 
[Smith & MacKenzie 2006]. For example, Williams et al. [1980] demonstrated that the 
patients having some items from Cook-Medley Hostility Inventory (CMHI) are more likely 
to experience coronary occlusions. A pattern of emotional negativity might be seen “as the 
most endemic heart of the TABP” [Donker 2000]. However, the evidence from the studies 
including women and non-Caucasian populations is limited; therefore it remains unclear 
whether the hostility is consistently associated with CVD risk [Everson-Rose & Lewis 2005]. 
Additionally, the term of hostility is relatively frequently used as a synonym for cynicism 
and cynical distrust, though strictly psychologically they are different entities of conceptual 
framework of psychology. 
Positive associations were supported by several studies with self-reported measures 
[Barefoot et al. 1983] [Shekelle et al. 1983] as well as meta-analysis [Miller et al. 1996]. 
Therefore, additionally to the TABP analyses in Kuopio Ischemic Heart Disease study, there 
have been conducted the calculations associated with the relationship of cynicism and 
mortality. The issue is that based on position statement of prospective studies by the 
National Heart Foundation of Australia [Bunker et al. 2003], one review concluded that 
there was consistent positive evidence of association, two other reviews reported an almost 
equal number of positive and negative studies in healthy populations, and the most recent 
review concluded that there was no evidence of association. The expert working group 
gave greater credence to better-quality ‘negative’ review and considered that hostility is not 
a risk factor for CHD (evidence rating C – “there is poor evidence of support”). 
Of the many self-reported instruments used in the research of hostility, the CMHI scale 
[Cook & Medley 1954] is the most widely used, in large part because it is from the 
Minnesota Multiphasic Inventory item pool [Smith & MacKenzie 2006]. In our study, the 
cynicism was assessed using the short version of Cook-Medley Hostility Inventory – the 
Cynical Distrust Scale. 
So, the Cynical Distrust Scale, like ‘the ugly duckling’ among the Type A scales has 
shown clear highest levels of risk for upper quartile. Quite many of findings for the 4th 
quartile compared to the 1st were statistically significant, especially starting from the year 10 
onwards. Thus, CVD mortality among CVD-free individuals during years 11 to 16 was as 
high as HRR=3.00 and above (P<0.05). Considerably different risks were observed for the 4th 
quartile among subjects with CVD history at baseline, ranging at levels of no-difference. 
Non-CVD mortality was slightly different from CVD mortality in that there were no 
statistically significant associations and lower risk estimates. At 26 years, the 4th quartile of 
cynicism had HRR=1.40 (P<0.05) risk for CVD death compared to HRR=1.20 for non-CVD 
death (P>0.05). 
In the KIHD sample the cynicism had very poor correlation with the TABP scales, 
correlation coefficient ranging from -0.04 to 0.15 and kappa statistic from 0.01 to 0.06 
(highest correlation with the Finnish Type A scale). The hostility and the TABP correlated 
poorly in some other studies as well [Lemogne et al. 2010], which means that they seem to 
be quite different personality features. 
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Concerning the associations between hostility and mortality, several studies can be 
compared with our findings. Thus, in KIHD study the hostility in terms of cynicism has 
been investigated already. This has been conducted with mortality and mean follow-up of 9 
years [Everson et al. 1997]. The CVD mortality risk for the 4th quartile was higher as well as 
non-CVD mortality, which is very close to our findings. The authors suppose that the 
differences they found between age-adjusted and risk-factors-adjusted estimates of 
association could be largely explained by the association of hostility and mortality. Thus, it 
seems that the cynicism in Kuopio middle-aged men sample was a robust risk factor for 
non-cardiovascular mortality in the first decade of follow-up. 
Meanwhile, McCranie et al. [1986] examined association of hostility assessed by CMHI 
and health status 25 years later in 478 physicians, who completed the MMPI at their 
admission to medical school. They found no evidence of significant association between 
hostility scores, CHD incidence or total mortality. To compare our study after 26 years of 
follow-up, we see that cynicism was associated with significant increase of CVD mortality 
but not non-CVD mortality; the highest risk was observed for CVD-free subsample 
(HRR=1.79, P<0.05). Thus, it seems that the negative effect of hostility for CVD mortality 
persists even for decades, especially in CVD-free men. 
Our findings are consistent with those of Barefoot et al. [1983] who established, that the 
high scores on the Cook-Medley scale predict all cause mortality and incidence of CHD. 
They stated that this relationship was independent of the individual effects of smoking 
status, age, family history of hypertension, and current hypertensive status. Also Shekelle 
et al. [1983] with the Western Electric Study population investigated, that the hostility 
scores for men aged 40–55 years at study entry were also related to the 10-year CHD 
mortality, but in a somewhat different way – the lowest risk was in the lowest quintile of 
hostility scores and the highest risk in the middle quintile, with the highest quintile being 
intermediate. Thus, it appears that in these two prospective studies, hostility scores were 
related to CHD morbidity and total mortality in a non-linear manner. Non-linearity of 
association between the cynicism and mortality was also observed in our study, though the 
highest risk of death in majority of cases still was among the highest levels of cynicism. 
Given the findings that the hostility scale gave the scores which are not associated with 
CHD in a linear manner, the question as to their proper interpretation emerges. Is a trusting 
attitude toward people a protective factor below some threshold or is the greater mistrust 
the greater the risk? The hostility scores were also related in these studies to mortality from 
the causes other than CHD. The non-specificity of hostility effect raises the question of 
whether or not a ‘new’ risk factor versus a component of TABP has been identified. A 
hostile attitude in the sense of a basic mistrust of others (the Cook-Medley scale definition, 
essentially similar to construct of cynical distrust) was not a part of the original description 
of TABP. Rather, the hostility aspect of the Type A was described as a free-floating and 
elicited by interruptions from persons and things in the environment that impede the Type 
A progress. Thus, it remains to be resolved what aspects of anger and hostility could be 
related to the Type A, to CHD, and to survival [Matthews & Haynes 1986]. According to 
Greenglass & Julkunen [1989] the cynical distrust was positively correlated with Anger-out 
in men. If, as others suggest, cynicism is the central concept being assessed in the Cook-
Medley scale, the relationship with CHD may be mediated by an interpersonal deficit, 
where a highly cynical person may be less receptive to social support, and this could lead to 
social isolation – a potential link between cynical distrust and disease. Earlier findings of 
associations between the TABP and negative health outcomes could be due to possible 
correlations between the TABP and cynicism or hostility in those study samples. 
The WCGS analyses showed that the anger and hostility are the main pathogenic 
elements [Matthews et al. 1977] [Chesney et al. 1981]. Similarly, the MRFIT study also 
found hostility and CHD association [Scherwitz et al. 1987] as well as Barefoot et al. [1983]. 
However, not all studies succeeded to show association, one of reasons to which could be 
that as Chesney et al. [1981] pointed that ‘toxic’ elements could be such TABP components 
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as fast speaking that are exclusively evaluated only during the SI but not with the 
questionnaire design. 
It can be concluded that the cynicism unlike the Type A seems to be a risk factor for CVD 
mortality and partly for non-CVD mortality. 
6.4 FUTURE PROSPECTS 
Type A behavior pattern has been investigated for almost 50 years, starting from original 
claims of Friedman & Rosenman [1959] on personality type, presumably associated with 
untoward health effects, especially related with cardiovascular system. It is them who 
elaborated the concept of Type A. The next two decades of research provided sufficient 
material for decision to consider the Type A as a conventional risk factor for CVD, such as 
the Western Collaborative Group Study ([Rosenman et al. 1975]) and the Framingham 
Heart Study ([Haynes et al. 1980]) that have demonstrated that TABP is associated with 
coronary heart disease. Consequently, by early 1980s the type A was characterized as a 
conventional coronary risk factor [Cooper et al. 1981]. It can be stated that the unambiguous 
results from the WCGS and FHS cohort studies were the main trials leading the Type A to 
the place of ‘culprit’ for CVD and mortality. 
The years from 1970 to 1980, when the evidence about untoward health effects of the 
Type A emerged from those studies, can be regarded as a publication bias decade because 
the later decades did not provide such strong evidence about the ‘toxicity’ of the TABP 
concept. This idea was supported by the review of Miller et al. [1991] who discovered that 
the studies published before 1978 were significantly more likely to have reported positive 
findings using both the Structured Interview and self-reported measurements. After 1978 
the studies were 4 times more likely to report null findings if assessment was made by the 
SI and 8 times if conducted using self-reported questionnaires. Moreover, some studies not 
only failed to show the association between TABP and negative health outcomes, but even 
provided the results with inverse associations, suggesting that the Type A can be 
hypothesized as a protective rather than risk factor for health. Our findings, based on a 
representative adult male sample from the KIHD study seem to support the later rather 
than the earlier trends of TABP research. 
In the context of TABP studies in Finland it can be noted that our study does not seem to 
be an outlier, since previously it was demonstrated that the Type A associations with health 
outcomes in Finland are rather meager, while the health outcomes more associate with the 
Type A component cynicism. 
There is not easy to decide exactly how the Type A is or is not a risk factor for mortality. 
There have been so many attempts to establish the effect of TABP on health and there are so 
many ambivalent as well as ‘null’ findings that there could be sufficient reason to revise the 
investigation of the Type A and health outcomes. Additional misunderstandings and 
hypotheses emerge with certain aspects of TABP. Presumably, the main toxic element in 
TABP could be the cynicism, which in our sample shows stronger associations than the 
Type A itself. 
Some more radical views are proposed already. Some authors claim that the Type A 
construct must be viewed as a false trail which should now be abandoned [Ray 1992]. Grief, 
hostility and social isolation, fear and work demands have each been implicated in heart 
disease independently of the Type A [Conduit 1992]. Gallacher [2008] suggests that the 
Type A as such is a pattern of American culture. It is primarily a challenge to a culture 
being increasingly predicated upon competition and material acquisition at the expense of 
more mature personal qualities. For example, the concept of ‘Karoshi’ in Japan, meaning 
the death through long working hours, can be more culturally meaningful health-related 
focus in Japan than the TABP. 
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By cultural differences there can also be explained the changes of associations between 
TABP and health outcomes. It can also be related with societal development or evolution of 
society. For instance, if manifesting of TABP was considered less socially accepted behavior 
in earlier decades of research (or societies there and then) compared to last decades, then 
the associations observed in 1970s or 1980s are more likely to be the outcome of dissonance 
(and related stress) between person’s perception of the self within that society (or culture) 
and behavioral expectations in that society. In the 21st century the Western style of life 
seems to promote the manifestation of TABP features and this is likely to get more 
universal and tolerated behavior, which in turn can lead to almost no negative effect of 
TABP on person’s health. In this perspective, the stress can act as a true trigger of poorer 
health, and if the Type A in certain sample correlates with the stress, this can result in 
similar association established between TABP and health. 
In general, the interaction between the personality and its environment (especially social 
and cultural) can play essential roles in mechanisms of positive or negative health effects 
whichever personal feature to regard. Possibly, the Type A as such needs more triggering, 
which makes Type A less similar to classical types of personality and following this the 
misunderstandings and ambiguities emerge. This person-environment interaction is similar 
like in a gene research, where the paradigm has shifted from a gene as the only trigger of 
diseases towards the gene-environment interaction which plays a crucial role in 
manifestation of many diseases. Thus, extrapolating this approach towards the issue of 
psychological phenomena it can be said that it is very much about environment whether 
the Type A manifests and what are the consequences of that (e.g. a person living in lonely 
hut in countryside and having very limited contacts to other people has very few 
opportunities to develop or manifest Type A). The effects on health can be both ways – to 
personality and from personality and the associations with health can be strongly 
dependent on interactions of social and individual factors. After all, the effects of 
personality on health can hardly be predicted due to the complexity of life and health as 
such. 
Additional detail to the picture could be the biography of Meyer Friedman (1910–2001), 
one of the main promoters of the Type A construct [Wikipedia 2012]: 
 
The early Friedman was classic Type A. Even before he finished junior high school he chose Yale 
University and Johns Hopkins Medical School. In the Army he was dubbed “Cannonball” for the 
way he charged down hallways to see patients, “as if they would evaporate before I got there.” If 
people didn’t talk fast enough, he’d break in with “Yup, yup, come to the point.” Much later he 
would observe that such frantic drive is not always the hallmark of a successful person. “Type A 
personalities who succeed do so in spite of their impatience and hostility,” he said, listing among the 
more notable Type Bs Winston Churchill, Harry Truman, Gerald Ford and Jimmy Carter. In his 
own case, formulating the theory of Type A behavior was just one of many achievements. Friedman 
contributed important discoveries in the study of gout and cholesterol and helped develop the 
angiogram. Friedman suffered an angina attack in 1955 when he was 45 and had the first of two 
heart attacks 10 years later at 55. As a result of this, Friedman attempted to alter his own type A 
personality to reduce stress. 
 
Not surprisingly, Friedman et al. [1986] demonstrated that the TABP can be modified 
and lead to decreased levels of cardiovascular risk. They followed up the study arms for 4.5 
years, the first being exposed to cardiac counseling, the second – to cardiac counseling as 
well as to TABP counseling, and the third – to no counseling. However, the question 
remains about the long-term maintenance of altered behavior as well as effective 
components of it. Moreover, talking about the TABP as exposure the potential for bias 
exists when re-reporting the personal traits after the intervention program. Later on, there 
was an attempt to review the treatment of TABP proposed by Friedman [Wikipedia 2012]: 
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In treatment programs, Friedman used a series of exercises to teach Type A’s to emulate the 
mellower, more thoughtful behavior of people with Type B personality. He would ask them to leave 
their watches home for a day, to drive in the slow lane, to pick the longest line in the grocery store, 
and consciously to observe and talk to other people. To force Type A’s to slow down, he prescribed 
reading Marcel Proust’s Remembrance of Things Past--all seven volumes. “He encouraged people to 
read any and all of the classics. He saw it as a way for people to re-energize or strengthen their right 
brain”--the creative side—“which he felt atrophied in people with Type A behavior,” said Dr. Barton 
Sparagon, medical director of the Meyer Friedman Institute at San Francisco’s Mount Zion Medical 
Center. Other sessions concentrated just on smiling because Type A’s more typically wore a hostile 
grimace. “Sweetness is not weakness,” Friedman would often tell his patients. When he encountered 
resistance, he quoted Hamlet: “Assume the virtue even if you have it not . . . for its use almost can 
change the stamp of nature.” 
 
The personal bias (Friedman’s input to the TABP concept and research) should not be 
excluded from the whole TABP research, especially keeping in mind that the main support 
of TABP and health outcomes association was provided namely by the construct authors 
and the longitudinal studies they launched. 
Possibly, the other CVD risk factors could eliminate or support the TABP–CVD 
relationship, and possibly, the associations found in this study could have confounding 
effect from some psychosocial or psychological variables. Even though there are still new 
Type A scales invented, most likely there is no necessity of a new assessment tool since 
there are many invented so far and they hardly can be compared since they measure 
slightly or strongly different aspects of personality. Also, there exists an issue of replication 
(repeatability) of scales worldwide concerning geographical differences in cultures, 
especially repeatability of positive findings. Additional severe problems arise due to 
categorization issues of exposure. 
In general it can be concluded, that at the moment there is limited justification for future 
scientific research on associations of the Type A and health outcomes: these associations are 
too much dependent on measurement scales, follow-up time, research decades, cohort 
characteristics, statistical assumptions, and environment while the statistically significant 
findings about associations can be random or specific to other components of personality or 
other behaviors. 
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7 Conclusions 
1) In our study, the Type A as measured by different scales tended to be inversely 
associated or not associated with cardiovascular mortality among middle-aged and 
aging men. 
2) The inverse associations between the Type A and cardiovascular mortality were more 
expressed among men with cardiovascular history at baseline than without. 
3) Non-cardiovascular mortality was associated with the Type A mainly in earlier 
follow-up until about 11 years while the later follow-up showed slight or no risk 
effect. 
4) The cynicism seemed to be associated with an increased risk of cardiovascular and 
non-cardiovascular death in middle-aged and aging men. 
5) The associations between the Type A and mortality strongly depended on the Type A 
scales that showed only moderate intercorrelations. Stronger associations were 
observed with the Framingham and Finnish than the Jenkins and Bortner scales, 
while the follow-up time was related with the strongest associations at about 6–11 
years of follow-up. 
6) There is limited justification for future scientific research on associations of the Type 
A and health outcomes: these associations are too much dependent on measurement 
scales, follow-up time, research decades, cohort characteristics, statistical 
assumptions, and environment while the statistically significant findings about 
associations can be random or specific to other components of personality or other 
behaviors. 
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Appendices 
Table A1. Socioeconomic covariates across Finnish Type A scale quartiles 
 
Covariate Category 
Quartiles 
P 
1st (n=625) 2nd (n=591) 3rd (n=539) 4th (n=548) 
Occupation Farmer 19.6% 15.8% 15.8% 11.8% < 0.001 
Blue-collar 46.7% 45.2% 42.8% 36.3%   
White-collar 33.8% 39.0% 41.3% 51.8%   
Education 0 10.7% 8.3% 9.3% 9.9% 0.015 
1 52.2% 48.8% 44.8% 42.0%   
2–4 32.0% 36.4% 38.3% 39.6%   
5 5.1% 6.4% 7.6% 8.6%   
Income Lowest 25.4% 17.1% 16.3% 16.0% < 0.001 
Low 21.7% 20.2% 20.0% 15.8%   
Medium 19.2% 23.4% 22.7% 16.8%   
High 19.9% 20.0% 19.3% 22.7%   
Highest 13.8% 19.3% 21.7% 28.7%   
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Table A2. Socioeconomic covariates across Jenkins Activity Survey scale quartiles 
 
Covariate Category 
Quartiles 
P 
1st (n=668) 2nd (n=643) 3rd (n=655) 4th (n=655) 
Occupation Farmer 16.9% 14.7% 16.8% 16.0% < 0.001 
Blue-collar 54.0% 47.6% 39.4% 34.4%   
White-collar 29.2% 37.7% 43.8% 49.6%   
Education 0 13.6% 7.6% 9.3% 8.4% < 0.001 
1 54.5% 49.0% 46.6% 41.0%   
2–4 27.8% 37.0% 36.0% 41.7%   
5 4.0% 6.4% 8.1% 8.9%   
Income Lowest 23.4% 18.3% 16.4% 18.8% < 0.001 
Low 25.0% 20.5% 19.5% 14.9%   
Medium 21.6% 21.1% 20.7% 16.5%   
High 16.9% 23.8% 20.6% 20.6%   
Highest 13.1% 16.2% 22.8% 29.1%   
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Table A3. Socioeconomic covariates across Bortner Rating Scale quartiles 
 
Covariate Category 
Quartiles 
P 
1st (n=942) 2nd (n=386) 3rd (n=856) 4th (n=424) 
Occupation Farmer 18.1% 16.3% 15.0% 13.8% < 0.001 
Blue-collar 49.3% 42.8% 40.9% 37.5%   
White-collar 32.6% 40.9% 44.0% 48.7%   
Education 0 11.1% 9.6% 9.0% 8.3% < 0.001 
1 52.9% 46.9% 46.0% 40.3%   
2–4 31.0% 35.2% 37.6% 42.4%   
5 5.0% 8.3% 7.4% 9.0%   
Income Lowest 21.2% 19.7% 17.4% 17.4% < 0.001 
Low 23.9% 17.6% 18.1% 17.4%   
Medium 21.4% 20.0% 21.0% 15.5%   
High 19.4% 22.1% 21.5% 19.3%   
Highest 14.1% 20.5% 22.0% 30.5%   
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Table A4. Socioeconomic covariates across Framingham Type A scale quartiles 
 
Covariate Category 
Quartiles 
P 
1st (n=677) 2nd (n=881) 3rd (n=470) 4th (n=589) 
Occupation Farmer 18.2% 14.6% 15.1% 17.0% < 0.001 
Blue-collar 50.6% 47.1% 38.1% 35.2%   
White-collar 31.2% 38.3% 46.9% 47.9%   
Education 0 10.7% 9.8% 9.2% 9.0% < 0.001 
1 56.1% 48.6% 43.9% 39.6%   
2–4 28.7% 34.7% 38.6% 42.8%   
5 4.4% 6.9% 8.3% 8.7%  
Income Lowest 21.6% 18.8% 17.2% 18.5% < 0.001 
Low 23.4% 22.5% 16.4% 15.2%   
Medium 23.4% 19.5% 20.5% 17.1%   
High 18.4% 20.6% 21.3% 21.3%   
Highest 13.1% 18.6% 24.6% 27.9%   
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Table A5. Socioeconomic covariates across Multiscale Assessment tertiles 
 
Covariate Category 
Tertiles 
P 
1st (n=1154) 2nd (n=656) 3rd (n=872) 
Occupation Farmer 17.5% 14.6% 15.6% 16.2% 
Blue-collar 50.6% 47.1% 33.8% 44.3% 
White-collar 31.9% 38.3% 50.6% 39.6% 
Education 0 10.6% 10.7% 8.7% 10.0% 
1 53.2% 50.0% 40.0% 48.1% 
2–4 31.1% 32.7% 42.3% 35.1% 
5 5.1% 6.6% 9.1% 6.8% 
Income Lowest 20.8% 22.5% 16.1% 19.7% 
Low 24.3% 18.1% 15.8% 20.0% 
Medium 20.8% 21.8% 17.7% 20.0% 
High 20.1% 19.2% 21.4% 20.3% 
Highest 14.0% 18.4% 29.0% 20.0% 
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Table A6. Socioeconomic covariates across Cynical Distrust Scale quartiles 
 
Covariate Category 
Quartiles 
P 
1st (n=708) 2nd (n=615) 3rd (n=409) 4th (n=557) 
Occupation Farmer 16.7% 18.4% 12.9% 14.1% < 0.001 
Blue-collar 34.2% 37.2% 51.0% 54.2%  
White-collar 49.1% 44.4% 36.1% 31.7%  
Education 0 6.8% 5.2% 12.2% 16.0% < 0.001 
1 41.7% 48.9% 47.4% 51.8%  
2–4 40.2% 38.4% 35.9% 29.9%  
5 11.3% 7.5% 4.4% 2.3%  
Income Lowest 14.6% 17.6% 18.6% 25.5% < 0.001 
Low 16.6% 18.3% 21.5% 23.9%  
Medium 19.1% 19.2% 22.0% 23.0%  
High 22.2% 22.0% 21.5% 15.0%  
Highest 27.4% 22.9% 16.3% 12.6%  
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Table A7. Biological covariates across Finnish Type A scale quartiles 
 
Covariate 
Quartiles 
P 1st (n=625) 2nd (n=591) 3rd (n=539) 4th (n=548) 
Mean SD Mean SD Mean SD Mean SD 
Physical activity, 
kcal/day 128.6 156.67 134.8 161.35 146.0 160.32 166.5 218.08 0.001 
Smoking, cigarettes 
× years 200.0 357.05 154.3 296.54 139.9 308.51 136.9 314.44 0.002 
BMI, kg/m2 26.7 3.61 26.8 3.49 26.8 3.56 27.0 3.43 0.622 
Alcohol 
consumption, 
g/week 62.4 98.79 75.6 137.36 78.3 145.65 77.9 112.09 0.084 
HDL/LDL ratio 0.4 0.15 0.3 0.13 0.3 0.15 0.4 0.14 0.180 
SBP, mm Hg 134.9 17.64 134.0 15.78 132.4 17.20 133.9 16.83 0.082 
Note: BMI – body mass index, HDL – high density lipoproteins, LDL – low density lipoproteins, SBP – 
systolic blood pressure. 
 
Table A8. Biological covariates across Jenkins Activity Survey scale quartiles 
 
Covariate 
Quartiles 
P 1st (n=668) 2nd (n=643) 3rd (n=655) 4th (n=655) 
Mean SD Mean SD Mean SD Mean SD 
Physical activity, 
kcal/day 116.7 145.83 143.1 169.33 149.4 185.91 157.6 196.70 < 0.001 
Smoking, cigarettes 
× years 192.8 323.53 167.8 331.43 153.7 341.56 168.7 362.27 0.220 
BMI, kg/m2 26.6 3.47 26.9 3.69 26.8 3.47 27.0 3.59 0.284 
Alcohol 
consumption, 
g/week 67.9 115.84 80.3 122.89 83.8 168.52 70.5 129.23 0.100 
HDL/LDL ratio 0.3 0.14 0.3 0.13 0.4 0.15 0.3 0.15 0.208 
SBP, mm Hg 134.6 17.82 135.2 17.36 133.3 15.56 133.7 17.64 0.163 
Note: BMI – body mass index, HDL – high density lipoproteins, LDL – low density lipoproteins, SBP – 
systolic blood pressure. 
 
80 
 
 
Table A9. Biological covariates across Bortner Rating Scale quartiles 
 
Covariate 
Quartiles 
P 1st (n=942) 2nd (n=386) 3rd (n=856) 4th (n=424) 
Mean SD Mean SD Mean SD Mean SD 
Physical activity, 
kcal/day 143.3 191.23 135.2 157.69 140.9 170.38 143.6 165.70 0.881 
Smoking, cigarettes 
× years 182.4 346.19 175.0 315.75 165.2 347.62 153.7 330.93 0.490 
BMI, kg/m2 26.8 3.59 26.9 3.49 26.7 3.54 27.1 3.53 0.524 
Alcohol 
consumption, 
g/week 69.4 112.66 74.7 111.21 82.5 167.84 68.7 104.09 0.147 
HDL/LDL ratio 0.3 0.13 0.3 0.13 0.4 0.16 0.4 0.14 0.021 
SBP, mm Hg 134.1 17.10 133.4 17.27 134.6 17.26 134.1 16.76 0.694 
Note: BMI – body mass index, HDL – high density lipoproteins, LDL – low density lipoproteins, SBP – 
systolic blood pressure. 
 
Table A10. Biological covariates across Framingham Type A scale quartiles 
 
Covariate 
Quartiles 
P 1st (n=677) 2nd (n=881) 3rd (n=470) 4th (n=589) 
Mean SD Mean SD Mean SD Mean SD 
Physical activity, 
kcal/day 131.3 161.57 140.9 166.60 149.7 211.03 147.4 174.92 0.268 
Smoking, cigarettes 
× years 184.4 336.86 161.8 335.05 160.9 328.63 171.0 349.69 0.562 
BMI, kg/m2 26.4 3.34 26.9 3.64 27.0 3.60 27.2 3.52 0.001 
Alcohol 
consumption, 
g/week 62.5 113.61 73.0 120.49 94.1 197.69 79.1 117.14 0.001 
HDL/LDL ratio 0.3 0.14 0.3 0.14 0.3 0.15 0.4 0.14 0.445 
SBP, mm Hg 135.2 17.36 134.3 17.13 134.0 17.36 133.0 16.60 0.143 
Note: BMI – body mass index, HDL – high density lipoproteins, LDL – low density lipoproteins, SBP – 
systolic blood pressure. 
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Table A11. Biological covariates across Multiscale Assessment tertiles 
 
Covariate 
Tertiles 
P 1st (n=1154) 2nd (n=656) 3rd (n=872) 
Mean SD Mean SD Mean SD 
Physical activity, kcal/day 129.5 161.18 142.9 165.68 154.3 197.40 140.9 
Smoking, cigarettes × years 187.1 344.14 156.5 306.44 167.4 363.21 173.2 
BMI, kg/m2 26.7 3.61 27.1 3.60 26.9 3.54 26.9 
Alcohol consumption, g/week 70.0 116.14 86.0 171.55 77.3 133.07 76.3 
HDL/LDL ratio 0.3 0.14 0.3 0.15 0.4 0.15 0.3 
SBP, mm Hg 134.9 17.24 133.5 16.57 133.8 17.31 134.2 
Note: BMI – body mass index, HDL – high density lipoproteins, LDL – low density lipoproteins, SBP – 
systolic blood pressure. 
 
Table A12. Biological covariates across Cynical Distrust Scale quartiles 
 
Covariate 
Quartiles 
P 1st (n=708) 2nd (n=615) 3rd (n=409) 4th (n=557) 
Mean SD Mean SD Mean SD Mean SD 
Physical activity, 
kcal/day 147.1 163.26 133.5 157.71 142.7 187.53 149.5 196.54 0.393 
Smoking, cigarettes 
× years 110.5 255.28 144.1 323.62 193.6 337.77 212.8 369.03 < 0.001 
BMI, kg/m2 26.4 3.37 26.6 3.15 26.7 3.66 27.5 3.88 < 0.001 
Alcohol 
consumption, 
g/week 60.9 101.52 66.8 103.40 77.0 119.61 94.3 166.85 < 0.001 
HDL/LDL ratio 0.4 0.13 0.3 0.13 0.3 0.15 0.3 0.16 0.241 
SBP, mm Hg 133.0 16.58 133.0 16.58 135.2 15.95 134.8 18.09 0.053 
Note: BMI – body mass index, HDL – high density lipoproteins, LDL – low density lipoproteins, SBP – 
systolic blood pressure. 
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Table A13. Finnish Type A Scale and mortality depending on follow-up time: Cox proportional hazards model 
 
Years of follow-up Quartile 
CVD CVD(–)* CVD(+)** non-CVD 
P HRR P HRR P HRR P HRR 
6 
1 0.278 1.000 0.503 1.000 0.533 1.000 0.133 1.000 
2 0.478 0.732 0.623 0.633 0.796 0.875 0.070 2.260 
3 0.560 1.263 0.362 2.047 0.706 1.197 0.157 1.957 
4 0.177 0.508 0.707 0.700 0.245 0.493 0.020 2.790 
11 
1 0.357 1.000 0.159 1.000 0.707 1.000 0.014 1.000 
2 0.741 0.921 0.444 1.339 0.389 0.745 0.334 1.294 
3 0.533 0.848 0.872 1.072 0.338 0.720 0.590 1.168 
4 0.081 0.612 0.092 0.402 0.349 0.729 0.003 2.092 
16 
1 0.205 1.000 0.258 1.000 0.293 1.000 0.120 1.000 
2 0.893 1.026 0.223 1.458 0.456 0.829 0.910 1.022 
3 0.570 0.889 0.723 1.133 0.297 0.763 0.926 0.981 
4 0.060 0.661 0.377 0.717 0.058 0.595 0.045 1.448 
21 
1 0.036 1.000 0.063 1.000 0.179 1.000 0.082 1.000 
2 0.707 1.061 0.251 1.327 0.816 0.952 0.023 0.701 
3 0.339 0.846 0.773 1.083 0.185 0.739 0.333 0.861 
4 0.016 0.642 0.081 0.578 0.053 0.642 0.905 1.018 
26 
1 0.010 1.000 0.021 1.000 0.164 1.000 0.363 1.000 
2 0.979 0.996 0.453 1.176 0.671 0.919 0.116 0.800 
3 0.488 0.898 0.701 1.095 0.274 0.794 0.538 0.916 
4 0.002 0.593 0.015 0.504 0.031 0.628 0.960 1.007 
Note: * CVD(–) subjects without CVD history at baseline, ** CVD(+) subjects with CVD history at baseline. 
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Table A14. Jenkins Activity Survey and mortality depending on follow-up time: Cox proportional hazards model 
 
Years of follow-up Quartile 
CVD CVD(–) CVD(+) Non-CVD 
P HRR P HRR P HRR P HRR 
6 
1 0.455 1.000 0.974 1.000 0.457 1.000 0.617 1.000 
2 0.723 1.125 0.979 1.017 0.877 1.064 0.213 1.544 
3 0.961 1.017 0.769 0.798 0.877 1.062 0.350 1.399 
4 0.240 0.642 0.829 1.160 0.225 0.579 0.282 1.472 
11 
1 0.501 1.000 0.611 1.000 0.722 1.000 0.968 1.000 
2 0.768 0.936 0.256 0.656 0.816 1.071 0.828 0.952 
3 0.765 0.935 0.481 0.766 0.934 1.025 0.680 0.909 
4 0.150 0.707 0.286 0.650 0.436 0.785 0.964 1.010 
16 
1 0.611 1.000 0.412 1.000 0.710 1.000 0.203 1.000 
2 0.460 0.873 0.146 0.631 0.830 0.951 0.646 0.926 
3 0.618 0.913 0.943 1.021 0.498 0.853 0.038 0.682 
4 0.185 0.776 0.449 0.785 0.290 0.773 0.668 0.929 
21 
1 0.227 1.000 0.976 1.000 0.225 1.000 0.146 1.000 
2 0.714 1.058 0.729 0.919 0.744 1.068 0.836 0.972 
3 0.822 0.966 0.777 0.930 0.885 0.971 0.034 0.729 
4 0.110 0.767 0.676 0.896 0.117 0.711 0.775 0.961 
26 
1 0.421 1.000 0.810 1.000 0.301 1.000 0.253 1.000 
2 0.995 0.999 0.485 0.858 0.845 1.038 0.908 0.985 
3 0.392 0.884 0.425 0.835 0.572 0.898 0.065 0.779 
4 0.160 0.811 0.913 0.976 0.131 0.738 0.672 0.946 
Note: * CVD(–) subjects without CVD history at baseline, ** CVD(+) subjects with CVD history at baseline. 
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Table A15. Bortner Rating Scale and mortality depending on follow-up time: Cox proportional hazards model 
 
Years of follow-up Quartile 
CVD CVD(–) CVD(+) Non-CVD 
P HRR P HRR P HRR P HRR 
6 
1 0.504 1.000 0.280 1.000 0.636 1.000 0.275 1.000 
2 0.179 0.561 0.249 0.286 0.438 0.688 0.338 0.645 
3 0.890 0.961 0.099 0.319 0.515 1.243 0.592 1.172 
4 0.732 1.127 0.938 0.952 0.722 1.163 0.170 1.579 
11 
1 0.972 1.000 0.840 1.000 0.771 1.000 0.461 1.000 
2 0.858 0.956 0.522 1.296 0.626 0.853 0.210 0.707 
3 0.747 1.066 0.702 0.876 0.512 1.176 0.960 0.990 
4 0.845 1.050 0.946 0.973 0.763 1.099 0.529 1.160 
16 
1 0.704 1.000 0.395 1.000 0.448 1.000 0.671 1.000 
2 0.664 0.915 0.503 1.277 0.333 0.785 0.348 0.829 
3 0.401 1.143 0.278 1.360 0.864 1.034 0.632 0.930 
4 0.862 1.036 0.090 1.708 0.236 0.721 0.677 1.080 
21 
1 0.369 1.000 0.786 1.000 0.294 1.000 0.625 1.000 
2 0.372 0.857 0.517 0.819 0.466 0.857 0.919 0.985 
3 0.572 1.078 0.592 1.123 0.868 1.029 0.217 0.857 
4 0.293 0.829 0.896 1.036 0.098 0.673 0.945 0.990 
26 
1 0.423 1.000 0.591 1.000 0.538 1.000 0.374 1.000 
2 0.227 0.823 0.258 0.726 0.459 0.862 0.600 1.074 
3 0.609 1.064 0.715 1.072 0.735 1.056 0.173 0.854 
4 0.622 0.925 0.872 1.039 0.322 0.810 0.979 0.996 
Note: * CVD(–) subjects without CVD history at baseline, ** CVD(+) subjects with CVD history at baseline. 
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Table A16. Framingham Type A Scale and mortality depending on follow-up time: Cox proportional hazards model 
 
Years of follow-up Quartile 
CVD CVD(–) CVD(+) Non-CVD 
P HRR P HRR P HRR P HRR 
6 
1 0.997 1.000 0.327 1.000 0.706 1.000 0.166 1.000 
2 0.908 1.038 0.083 3.383 0.395 0.719 0.426 1.319 
3 0.835 1.081 0.620 1.597 0.911 1.046 0.031 2.236 
4 0.984 1.007 0.184 3.007 0.478 0.748 0.205 1.620 
11 
1 0.643 1.000 0.541 1.000 0.708 1.000 0.050 1.000 
2 0.835 1.044 0.184 1.576 0.534 0.848 0.494 1.165 
3 0.385 0.796 0.942 1.035 0.450 0.788 0.009 1.895 
4 0.506 0.851 0.619 1.241 0.253 0.714 0.189 1.386 
16 
1 0.440 1.000 0.138 1.000 0.900 1.000 0.121 1.000 
2 0.686 1.069 0.136 1.490 0.650 0.907 0.470 0.886 
3 0.284 0.795 0.462 0.744 0.518 0.847 0.095 1.360 
4 0.502 0.878 0.703 0.872 0.511 0.857 0.730 1.066 
21 
1 0.112 1.000 0.088 1.000 0.749 1.000 0.013 1.000 
2 0.514 1.095 0.411 1.192 0.687 1.078 0.415 0.898 
3 0.179 0.785 0.207 0.674 0.689 0.914 0.042 1.346 
4 0.217 0.814 0.164 0.663 0.588 0.894 0.323 0.859 
26 
1 0.038 1.000 0.030 1.000 0.491 1.000 0.022 1.000 
2 0.388 1.117 0.643 1.091 0.304 1.200 0.795 0.969 
3 0.179 0.801 0.156 0.680 0.883 0.969 0.044 1.318 
4 0.115 0.784 0.027 0.554 0.776 0.946 0.273 0.855 
Note: * CVD(–) subjects without CVD history at baseline, ** CVD(+) subjects with CVD history at baseline. 
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Table A17. Multiscale Assessment and mortality depending on follow-up time: Cox proportional hazards model 
 
Years of follow-up Tertile 
CVD CVD(–) CVD(+) Non-CVD 
P HRR P HRR P HRR P HRR 
6 
1 0.634 1.000 0.724 1.000 0.414 1.000 0.103 1.000 
2 0.390 1.291 0.707 0.758 0.247 1.479 0.996 1.002 
3 0.995 1.002 0.578 1.376 0.979 0.991 0.053 1.706 
11 
1 0.663 1.000 0.763 1.000 0.850 1.000 0.135 1.000 
2 0.991 0.998 0.731 0.884 0.880 1.039 0.700 0.920 
3 0.401 0.851 0.468 0.779 0.666 0.903 0.098 1.359 
16 
1 0.788 1.000 0.815 1.000 0.756 1.000 0.306 1.000 
2 0.682 1.069 0.523 1.195 0.974 0.993 0.670 0.933 
3 0.733 0.948 0.791 1.075 0.488 0.876 0.229 1.190 
21 
1 0.473 1.000 0.651 1.000 0.675 1.000 0.848 1.000 
2 0.759 1.042 0.617 1.118 0.955 0.990 0.812 0.970 
3 0.334 0.880 0.588 0.884 0.407 0.872 0.695 1.048 
26 
1 0.443 1.000 0.423 1.000 0.791 1.000 0.787 1.000 
2 0.582 1.071 0.475 1.148 0.887 1.024 0.580 1.066 
3 0.404 0.903 0.448 0.857 0.584 0.919 0.548 1.069 
Note: * CVD(–) subjects without CVD history at baseline, ** CVD(+) subjects with CVD history at baseline. 
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Table A18. Cynical Distrust Scale and mortality depending on follow-up time: Cox proportional hazards model 
 
Years of follow-up Quartile 
CVD CVD(–) CVD(+) Non-CVD 
P HRR P HRR P HRR P HRR 
6 
1 0.532 1.000 0.111 1.000 0.764 1.000 0.847 1.000 
2 0.602 1.273 0.055 8.422 0.469 0.661 0.761 1.137 
3 0.376 0.591 0.964 0.932 0.340 0.535 0.906 1.057 
4 0.748 1.159 0.280 3.530 0.744 0.847 0.413 1.392 
11 
1 0.427 1.000 0.061 1.000 0.767 1.000 0.091 1.000 
2 0.375 1.295 0.030 2.947 0.453 0.753 0.473 0.823 
3 0.485 1.247 0.430 1.583 0.795 1.104 0.383 0.767 
4 0.104 1.576 0.017 3.260 0.985 1.006 0.189 1.376 
16 
1 0.075 1.000 0.010 1.000 0.586 1.000 0.033 1.000 
2 0.450 1.190 0.063 2.048 0.633 0.869 0.816 0.955 
3 0.193 1.367 0.256 1.632 0.405 1.275 0.429 0.835 
4 0.013 1.704 0.001 3.236 0.655 1.127 0.056 1.426 
21 
1 0.079 1.000 0.063 1.000 0.516 1.000 0.117 1.000 
2 0.929 0.984 0.504 1.208 0.620 0.886 0.369 0.872 
3 0.367 1.189 0.431 1.270 0.446 1.209 0.195 0.798 
4 0.032 1.444 0.011 1.968 0.446 1.186 0.350 1.148 
26 
1 0.071 1.000 0.046 1.000 0.612 1.000 0.018 1.000 
2 0.879 0.975 0.840 1.051 0.890 0.969 0.346 0.876 
3 0.356 1.174 0.496 1.195 0.340 1.251 0.093 0.760 
4 0.031 1.401 0.011 1.790 0.428 1.183 0.175 1.201 
Note: * CVD(–) subjects without CVD history at baseline, ** CVD(+) subjects with CVD history at baseline. 
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The concept of Type A behavior 
(personality) was introduced in late 
1950s. It evolved from a relatively 
unknown factor to a widely popular 
concept of health research especially 
in 1970s and 1980s, conceived as 
equal to conventional cardiovascular 
risk factors. Since then, research 
findings on the relationship of Type 
A with cardiovascular outcomes 
have been inconsistent, and general 
interest towards this phenomenon has 
decreased remarkably. The findings 
of this study suggest that widely used 
Type A measures do not significantly 
associate with increased mortality.
